JP6736075B1 - Drug feeder - Google Patents

Drug feeder Download PDF

Info

Publication number
JP6736075B1
JP6736075B1 JP2020012127A JP2020012127A JP6736075B1 JP 6736075 B1 JP6736075 B1 JP 6736075B1 JP 2020012127 A JP2020012127 A JP 2020012127A JP 2020012127 A JP2020012127 A JP 2020012127A JP 6736075 B1 JP6736075 B1 JP 6736075B1
Authority
JP
Japan
Prior art keywords
drug
medicine
annular
rotating body
rotary body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020012127A
Other languages
Japanese (ja)
Other versions
JP2021115362A (en
Inventor
義人 大村
義人 大村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tosho Inc
Original Assignee
Tosho Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosho Inc filed Critical Tosho Inc
Priority to JP2020012127A priority Critical patent/JP6736075B1/en
Application granted granted Critical
Publication of JP6736075B1 publication Critical patent/JP6736075B1/en
Priority to EP21747412.1A priority patent/EP4098594A4/en
Priority to PCT/JP2021/003052 priority patent/WO2021153674A1/en
Priority to CN202180011421.2A priority patent/CN115038422A/en
Priority to CA3169692A priority patent/CA3169692A1/en
Priority to US17/795,695 priority patent/US11759396B2/en
Publication of JP2021115362A publication Critical patent/JP2021115362A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

【課題】二重回転タイプ薬剤フィーダを踏襲しつつ環状回転体の改良にて転動容易な薬剤までも能率良く送り出せる薬剤フィーダを実現する。【解決手段】縦線中心で軸回転する外側の環状回転体200と、傾斜線中心で軸回転する内側の傾斜回転体300と、その回転にて傾斜回転体300の上から環状回転体200の上端周縁部230上に運ばれた固形の薬剤を整列させる仕分け機構600と規制機構700とを備えた薬剤フィーダ100について、周方向に列なる菱形や紡錘形の溝231を環状回転体200の上端周縁部230に形成する。また、上端周縁部230の外周部分に面取232を形成し、そこに溝231を至らせる。さらに、落下排出口14寄りの部位を高める向きに環状回転体200を少し傾ける。その傾斜βは面取角度αより小さくする。【選択図】 図3PROBLEM TO BE SOLVED: To realize a drug feeder capable of efficiently delivering even a drug that easily rolls by improving an annular rotating body while following a double rotation type drug feeder. SOLUTION: An outer ring-shaped rotary body 200 axially rotates about a vertical line, an inner tilted rotary body 300 axially rotates about a tilted line, and the rotation of the ring-shaped rotary body 200 from above the tilted rotary body 300. In the medicine feeder 100 including the sorting mechanism 600 and the regulating mechanism 700 for aligning the solid medicines carried on the upper end peripheral portion 230, the diamond-shaped or spindle-shaped grooves 231 arranged in the circumferential direction are formed in the upper end peripheral edge of the annular rotating body 200. It is formed in the part 230. Further, a chamfer 232 is formed on the outer peripheral portion of the upper end peripheral portion 230, and the groove 231 is provided there. Further, the annular rotating body 200 is slightly tilted in such a direction as to raise the portion near the drop discharge port 14. The inclination β is smaller than the chamfer angle α. [Selection diagram]

Description

この発明は、病院や薬局等で行われる調剤を自動化するために、錠剤やアンプル剤といった粒状固形物の薬剤を自動供給するようになった薬剤フィーダに関し、詳しくは、形状の同じ多数の薬剤をランダム収容するとともに、それらの薬剤を回転体で整列させることで、それらの薬剤を一つずつ送り出す逐次送出・順次排出を行う薬剤フィーダに関し、更に詳しくは、回転体のうち環状回転体の改良に関する。 The present invention relates to a drug feeder adapted to automatically supply a granular solid drug such as a tablet or an ampoule in order to automate the dispensing performed in a hospital or a pharmacy. The present invention relates to a drug feeder that sequentially stores and sequentially discharges these drugs by randomly storing them and aligning the drugs with a rotating body. More specifically, it relates to an improvement of an annular rotating body of the rotating body. ..

同一形状の錠剤等(薬剤)を一列に整列させながら搬送する整列供給式の薬剤フィーダとして、鉛直線を中心として軸回転可能な外側の環状回転体と、鉛直から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる規制部材とを備えた薬剤フィーダが実用化されている(例えば特許文献1参照)。 As an array feed type drug feeder that conveys tablets (medicines) of the same shape while arranging them in a line, it is an outer ring-shaped rotating body that can rotate about a vertical line and an axis about an inclined line inclined from the vertical. An inclined rotary body that is rotatably mounted inside the annular rotary body and closes the hollow of the annular rotary body, and a tilted rotary body rotates to move the inclined rotary body from above to the upper edge portion of the annular rotary body. A drug feeder including a regulating member that aligns the spilled solid drug when the annular rotating body is rotated has been put into practical use (see, for example, Patent Document 1).

そのうち本願発明の理解に役立つ部分を、図面を引用して具体的に説明する(図9〜図13参照)。図9は、薬剤フィーダ10のほぼ全容を示しており、(a)が平面図、(b)が縦断正面図である。また、図10は、(a)が、最上部に配設されたリンク機構73や周壁11の上層部分を取り外したところの平面図、(b)が、それらに加えて周壁11とその装着物60,71,72も取り外したところの平面図である。さらに、図11は、(a)が、仕分け部材60の正面図と右側面図と右側面図であり、(b)は、フィーダ要部の展開図であって、周壁11等と回転容器20+30は縦断面を図示し、回転駆動機構50と回転伝動部材42,43は外観を図示している。 Of these, a part useful for understanding the present invention will be specifically described with reference to the drawings (see FIGS. 9 to 13 ). 9A and 9B show almost the entire contents of the medicine feeder 10, where FIG. 9A is a plan view and FIG. 9B is a vertical sectional front view. Further, FIG. 10A is a plan view of the uppermost portion of the link mechanism 73 and the peripheral wall 11 disposed at the uppermost part, and FIG. 10B is a plan view thereof in addition to them. It is a top view which removed 60,71,72. Further, FIG. 11A is a front view, a right side view, and a right side view of the sorting member 60, and FIG. 11B is a development view of a feeder main part, in which the peripheral wall 11 and the rotary container 20+30 are shown. Shows a longitudinal section, and the rotary drive mechanism 50 and the rotary transmission members 42 and 43 show external appearances.

薬剤フィーダ10は、二重回転タイプのものであり、筐体の最上部に位置しており中央部分が円形に刳り抜かれて中空になっている周壁11と、その中空に上端部が遊嵌された状態で設置されている又は周壁11の中空の直下に設置されている環状回転体20と、この環状回転体20の中空内に設置された傾斜回転体30と、この内側の傾斜回転体30とその外側の環状回転体20とを何れも軸回転可能に支持する支承機構40と、それらの回転の駆動を担う回転駆動機構50と、周壁11の上側に設けられた仕分け部材60及び規制機構70とを具えている。 The drug feeder 10 is of a double-rotation type, and is a peripheral wall 11 which is located at the uppermost part of the housing and hollowed out by hollowing out a central part in a circular shape, and an upper end part of which is loosely fitted in the hollow part. The ring-shaped rotary body 20 installed in a closed state or directly below the hollow of the peripheral wall 11, the tilted rotary body 30 installed in the hollow of the ring-shaped rotary body 20, and the tilted rotary body 30 inside thereof. A support mechanism 40 that supports both the rotary body 20 and the outer ring-shaped rotary body 20 so as to be rotatable about the axis, a rotation drive mechanism 50 that drives the rotation of the support body 40, a sorting member 60 and a regulation mechanism provided on the upper side of the peripheral wall 11. 70 and.

しかも、支承機構40によって、環状回転体20は鉛直線を中心として軸回転しうる状態に保たれ、傾斜回転体30は鉛直から傾いた傾斜線を中心として軸回転しうる状態に保たれる。そして、そのような内側の傾斜回転体30と外側の環状回転体20は、薬剤は通さないが回転は許容される僅かな間隙を保って傾斜回転体30が環状回転体20の中空を塞ぐことで、二重回転タイプ薬剤フィーダの回転容器20+30を構成しており、傾斜回転体30の回転による持ち上げと仕分け部材60の仕分けとによって傾斜回転体30の周縁部33の上から薬剤を環状回転体20の上端周縁部23の上に運び、環状回転体20の回転による水平搬送と規制機構70の整列機能とにて上端周縁部23の上の薬剤を整列させながら落下排出口14へと運ぶようになっている。以下、各部を説明する。 Moreover, the support mechanism 40 keeps the annular rotary body 20 axially rotatable about the vertical line, and keeps the inclined rotary body 30 axially rotatable about the inclined line inclined from the vertical. The inclined rotary body 30 and the outer ring-shaped rotary body 20 are arranged such that the tilted rotary body 30 closes the hollow of the ring-shaped rotary body 20 while keeping a slight gap in which medicine is not passed but rotation is allowed. In addition, the rotary container 20+30 of the double rotation type drug feeder is configured, and the drug is annularly rotated from above the peripheral portion 33 of the tilting rotary body 30 by lifting the tilting rotary body 30 by rotation and sorting the sorting member 60. 20 is carried on the upper end peripheral portion 23, and the medicine on the upper end peripheral portion 23 is aligned while being horizontally conveyed by the rotation of the annular rotating body 20 and the aligning function of the regulation mechanism 70, and is conveyed to the drop discharge port 14. It has become. Each part will be described below.

環状回転体20は(図9〜図11参照)、大別して、中空の径が上側ほど大きい下部21と、中空の径が上側ほど小さい上部22とからなり、下部21の中空に傾斜回転体30を納め、下部21に上部22を載せ、それから両部21,22をボルト等で連結することで、環状回転体20自体が一体的になるとともに(図11(b)参照)、傾斜回転体30とも分離不能になって、傾斜回転体30の軸回転等は許すが、環状回転体20と傾斜回転体30との何れかを持ち上げたりすると両者20,30が恰も一つの回転容器20+30のように一緒に移動するようになっている。 The annular rotating body 20 (see FIGS. 9 to 11) is roughly divided into a lower portion 21 having a larger hollow diameter toward the upper side and an upper portion 22 having a smaller hollow diameter toward the upper side. By placing the upper part 22 on the lower part 21 and connecting the two parts 21 and 22 with bolts or the like, the annular rotating body 20 itself becomes integral (see FIG. 11(b)), and the inclined rotating body 30 Both of them become inseparable and the axial rotation of the tilting rotary body 30 is allowed, but if either the annular rotary body 20 or the tilting rotary body 30 is lifted, both of them 20 and 30 look like one rotary container 20+30. It is designed to move together.

傾斜回転体30は(図9〜図11参照)、その上面が回転容器20+30の内底になるが、その上面の中央に中央突起31が形成されていて、中央突起31を持てば回転容器20+30を纏めて持ち上げることができるようになっている。
また(図9(b),図11(b)参照)、傾斜回転体30の上面は、中央突起31を除く央部32が中央突起31や周縁部33より凹んでいて、回転容器20+30の内部空間を増加させている。
The inclined rotating body 30 (see FIGS. 9 to 11) has an upper surface serving as an inner bottom of the rotating container 20+30, but a central protrusion 31 is formed at the center of the upper surface. It is possible to lift all together.
Further (see FIGS. 9B and 11B ), the upper surface of the inclined rotating body 30 has a central portion 32 excluding the central protrusion 31 which is recessed from the central protrusion 31 and the peripheral edge portion 33, so that the inside of the rotary container 20+30. The space is increasing.

さらに、傾斜回転体30の周縁部33の上面は、一周に亘って、薬剤の掬い上げに役立つ緩い鋸歯状波形に加工されているうえ(図9(a),図10参照)、外側ほど即ち中央から遠くへ離れるほど下がる謂わば外下がりの状態になっている(図9(b),図11(b)参照)。しかも、この外下がりは、環状回転体20の中に傾斜回転体30が傾斜設置された状態で、周縁部33のどの部位でも、特に外下がりが最も緩くなる最上昇位置で環状回転体20の上端周縁部23より上に来た部位でも、外下がり傾斜が維持されるので、掬い上げた薬剤を傾斜による転がりにて円滑に環状回転体20の上端周縁部23へ送り込むのに役立つ。 Further, the upper surface of the peripheral edge portion 33 of the inclined rotating body 30 is processed into a gentle serrated waveform that is useful for scooping up the medicine over the entire circumference (see FIGS. 9A and 10), and the outer side It is in a so-called outward falling state in which it is lowered as it goes away from the center (see FIGS. 9B and 11B). Moreover, this outward descent is such that at any position of the peripheral edge portion 33, especially when the inclined rotary body 30 is obliquely installed in the annular rotary body 20, the annular rotary body 20 is at the highest rising position where the outward descent is the slowest. Even at a portion above the upper end peripheral portion 23, the outer downward inclination is maintained, which helps the scooped medicine to be smoothly sent to the upper end peripheral portion 23 of the annular rotary body 20 by rolling due to the inclination.

支承機構40は(図9(b),図11(b)参照)、各所に分散して配設された複数の部材41〜43からなり、それには例えばラジアル軸受などを主体とした受動部材41が幾つかと、例えば硬質ゴム製Oリングなどの輪状体・環状体からなる回転伝動部材42,43とが含まれている。
受動部材41は、回転体の外周面を環状回転体20の外周面や下面あるいは傾斜回転体30の下面に当接させて、環状回転体20と傾斜回転体30を自転容易状態で固定位置に保持する支承専用のものとなっている。
The support mechanism 40 (see FIGS. 9(b) and 11(b)) is composed of a plurality of members 41 to 43 which are dispersedly arranged at various places, for example, a passive member 41 mainly including a radial bearing or the like. And a rotary transmission member 42, 43 formed of a ring-shaped body/annular body such as a hard rubber O-ring.
The passive member 41 brings the outer peripheral surface of the rotating body into contact with the outer peripheral surface or the lower surface of the annular rotating body 20 or the lower surface of the tilting rotating body 30 to bring the annular rotating body 20 and the tilting rotating body 30 into a fixed position in an easily rotatable state. It is only for bearings to hold.

これに対し、回転伝動部材42,43は、何れも、後述する回転駆動部材51に装着されて回転伝動機能を発揮するのに加えて、受動部材41と共に環状回転体20と傾斜回転体30とを支承してそれら20,30を自転容易状態で固定位置に保持する機能も発揮するので、支承部材を兼用するものとなっている。しかも、支承部材41〜43が何れも環状回転体20と傾斜回転体30の下面か外周面に当接するところに配設されているので、支承機構40は、環状回転体20と傾斜回転体30とからなる回転容器20+30を上から下ろして支承部材41〜43の上に乗せることで適切にセットでき、回転容器20+30を持ち上げることで簡便に支承部材41〜43から取り外せるようになっている。 On the other hand, each of the rotation transmission members 42 and 43 is mounted on the rotation drive member 51 described later to exert the rotation transmission function, and in addition to the passive member 41, the annular rotation body 20 and the inclined rotation body 30. Since it also has a function of supporting the bearings 20 and 30 and holding them in a fixed position in a state where they can easily rotate, they also serve as bearing members. Moreover, since the supporting members 41 to 43 are all disposed in contact with the lower surface or the outer peripheral surface of the annular rotating body 20 and the inclined rotating body 30, the supporting mechanism 40 includes the annular rotating body 20 and the inclined rotating body 30. The rotary container 20+30 composed of and is placed on the support members 41 to 43 from the top and can be set appropriately, and the rotary container 20+30 can be easily removed from the support members 41 to 43 by lifting.

回転駆動機構50は(図9(b),図11(b)参照)、回転容器20+30の下に配置された回転駆動部材51と、この回転駆動部材51を軸回転させる回転駆動モータ54とを具備したものであるが、上述したように支承機構40の回転伝動部材42,43は回転駆動機構50の一部でもある。
具体的には、大径部外装回転伝動部材42は、回転駆動部材51の大径部52に形成された環状溝に内側部分を収めた状態で外装されて(図11(b)参照)、環状回転体20の支承に加え環状回転体20に対して摩擦伝動による回転伝動機能も担うものとなっている(図9(b)参照)。
The rotary drive mechanism 50 (see FIGS. 9B and 11B) includes a rotary drive member 51 arranged below the rotary container 20+30, and a rotary drive motor 54 for axially rotating the rotary drive member 51. Although provided, the rotation transmission members 42 and 43 of the support mechanism 40 are also a part of the rotation drive mechanism 50 as described above.
Specifically, the large-diameter portion exterior rotation transmission member 42 is exteriorly packaged with the inner portion housed in an annular groove formed in the large-diameter portion 52 of the rotation driving member 51 (see FIG. 11(b)), In addition to supporting the annular rotating body 20, it also has a rotation transmission function by friction transmission with respect to the annular rotating body 20 (see FIG. 9B).

また、小径部外装回転伝動部材43は、回転駆動部材51の小径部53に形成された環状溝に内側部分を収めた状体で外装されて(図11(b)参照)、傾斜回転体30の支承に加え傾斜回転体30に対して摩擦伝動による回転伝動機能も担うものとなっている(図9(b)参照)。
そのため、回転駆動機構50は、回転駆動モータ54にて回転駆動部材51を軸回転させることで、環状回転体20を比較的高速で軸回転させるとともに、傾斜回転体30を比較的低速で軸回転させるものとなっている。
Further, the small-diameter portion exterior rotation transmission member 43 is exteriorly packaged by a body in which the inner portion is housed in an annular groove formed in the small-diameter portion 53 of the rotation driving member 51 (see FIG. 11B), and the tilted rotary body 30. In addition to the above-mentioned bearing, it also has a rotation transmission function by friction transmission for the inclined rotating body 30 (see FIG. 9B).
Therefore, the rotary drive mechanism 50 axially rotates the rotary drive member 51 by the rotary drive motor 54 to rotate the annular rotary body 20 at a relatively high speed and at the same time rotate the inclined rotary body 30 at a relatively low speed. It is supposed to be.

仕分け部材60は(図9〜図11参照)、揺動支点の基端部61から揺動端の先端部62まで延びた細長い棒材を主体としたものであり、基端部61が支持部63によって周壁11や環状回転体20の上方で支持されており、そこを中心にして先端部62が上下に揺動しうるようになっている。先端部62寄りの部分が少し曲がっており、常態では先端部62が斜め下向きの状態で自重により軽く傾斜回転体30の周縁部33に乗っているので、その周縁部33から環状回転体20の上端周縁部23へ滑り落ちることなく周縁部33に乗ったまま運ばれて来た薬剤の多くが、先端部62に当接するとともに、その反作用の付勢力によって傾斜回転体30の央部32へ戻されるが、それが円滑に行われなければ薬剤破損等の回避のため先端部62が揺動して上方へ逃げるようにもなっている。 The sorting member 60 (see FIGS. 9 to 11) is mainly composed of an elongated bar member extending from the base end portion 61 of the swinging fulcrum to the tip end portion 62 of the swinging end, and the base end portion 61 is a supporting portion. It is supported above the peripheral wall 11 and the annular rotating body 20 by 63, and the tip portion 62 can be vertically swung about this. The portion near the tip portion 62 is slightly bent, and in the normal state, the tip portion 62 is lightly riding on the peripheral edge portion 33 of the inclined rotary body 30 with its own weight in a diagonally downward state. Most of the medicine carried on the peripheral edge portion 33 without slipping down to the upper end peripheral edge portion 23 comes into contact with the distal end portion 62 and is returned to the central portion 32 of the inclined rotary body 30 by the biasing force of its reaction. However, if this is not done smoothly, the tip 62 swings to escape upward in order to avoid damage to the medicine or the like.

規制機構70は(図9,図10(a)参照)、環状回転体20の上端周縁部23の回転方向を基準として仕分け部材60より進行先に設置された第1規制部材71と、それよりも更に進行先に設置された第2規制部材72と、それら第1規制部材71と第2規制部材72との何れにもピン状の回転許容軸部材等を介して連結されているリンク機構73と、サンプル薬剤を収容しうる型置場74とを具備している。
第1規制部材71も、第2規制部材72も、揺動中心部が周壁11側に位置するとともに、揺動端部が環状回転体20の上端周縁部23の上に位置しているので、その上端周縁部23の上の薬剤搬送経路幅を外周側から狭めるものとなっている。
The restricting mechanism 70 (see FIGS. 9 and 10A) includes a first restricting member 71 installed ahead of the sorting member 60 with respect to the rotation direction of the upper end peripheral portion 23 of the annular rotating body 20, and the first restricting member 71. Further, the second restricting member 72 installed further ahead and the link mechanism 73 connected to both of the first restricting member 71 and the second restricting member 72 via a pin-shaped rotation permitting shaft member or the like. And a mold storage area 74 capable of containing a sample drug.
Since both the first restricting member 71 and the second restricting member 72 have the swing center portion on the peripheral wall 11 side and the swing end portion on the upper end peripheral portion 23 of the annular rotating body 20, The drug delivery path width on the upper edge portion 23 is narrowed from the outer peripheral side.

しかも、第1規制部材71と第2規制部材72は、何れも揺動にて上端周縁部23の上の薬剤搬送経路幅の狭め量を可変調整しうるものであるが、リンク機構73の長手方向進退に応じて両規制部材71,72が同時かつ同様に揺動するので、両規制部材71,72による薬剤搬送経路幅の狭め量の調整量が連動するものともなっている。さらに、型置場74にサンプル薬剤を収容してから、それに向けてリンク機構73を動かすと、リンク機構73が長手方向に進んで先端をサンプル薬剤に当接させて止められるが、そのときに第1規制部材71の揺動端部と第2規制部材72の揺動端部が何れも上端周縁部23の上の薬剤搬送経路幅をサンプル薬剤に倣って薬剤一個相当分に狭めるようにもなっている。 Moreover, both the first restricting member 71 and the second restricting member 72 are capable of variably adjusting the narrowing amount of the drug transport path width on the upper end peripheral portion 23 by swinging. Both regulation members 71 and 72 swing simultaneously and similarly in accordance with the advance/retreat in the direction, so that the adjustment amount of the narrowing amount of the drug transport path width by both regulation members 71 and 72 is also interlocked. Further, when the sample drug is stored in the mold storage space 74 and then the link mechanism 73 is moved toward it, the link mechanism 73 advances in the longitudinal direction and the tip is brought into contact with the sample drug and can be stopped. Both the swinging end of the first restricting member 71 and the swinging end of the second restricting member 72 narrow the drug transport path width on the upper end peripheral portion 23 to the amount equivalent to one drug following the sample drug. ing.

また、そのような規制機構70より更なる進行先では、周壁11に、それを上下に貫通する落下排出口14が形成されており、そこへ環状回転体20の上端周縁部23の上の薬剤を環状回転体20の回転にて送り込むために周壁11には排出ガイド13も設けられている。この排出ガイド13は、落下排出口14の後方の周壁11から始まって、上端周縁部23の上方に延び、更に先端部を傾斜回転体30の周縁部33の上方にまで突き出しているので、環状回転体20の排出ガイド13に乗って運ばれてきた薬剤が、排出ガイド13の側壁に斜めに当接して、それから側壁に沿って斜めに進んで、落下排出口14に至るようになっている。 Further, in a further advance destination than the regulation mechanism 70, the peripheral wall 11 is formed with a drop discharge port 14 which vertically penetrates the peripheral wall 11, to which the medicine on the upper end peripheral portion 23 of the annular rotary member 20 is formed. A discharge guide 13 is also provided on the peripheral wall 11 in order to feed by the rotation of the annular rotary body 20. This discharge guide 13 starts from the peripheral wall 11 behind the drop discharge port 14, extends above the upper end peripheral edge portion 23, and further projects the tip end portion above the peripheral edge portion 33 of the inclined rotating body 30. The medicine carried on the discharge guide 13 of the rotating body 20 obliquely comes into contact with the side wall of the discharge guide 13, and then advances obliquely along the side wall to reach the drop discharge port 14. ..

さらに、この排出ガイド13の先端部には、そこより下側に延び且つ先にも延びて最先端となる搬送面ガイド12が形成されている。この搬送面ガイド12は、上面が環状回転体20の上端周縁部23とほぼ同じ高さであって、上端周縁部23の内周側に位置しているので、環状回転体20の上端周縁部23に乗って運ばれてきた薬剤が排出ガイド13に当接したときに反動で傾斜回転体30の方へ落下したり環状回転体20と排出ガイド13とに挟まれたりといった不所望な事態の発生を簡便に防止するものとなっている。
なお、細かな形状なので図示は割愛したが、薬剤が排出ガイド13によって落下排出口14へ押し出される前に慣性等で落下排出口14へ転げ落ちるのを簡便に防止するために、上端周縁部23の上面は最外周部分が僅かに盛り上がっている。
Further, at the tip of the discharge guide 13, there is formed a conveyance surface guide 12 that extends downward and also extends to the front end to become the leading edge. Since the upper surface of the transport surface guide 12 is approximately the same height as the upper end peripheral portion 23 of the annular rotating body 20 and is located on the inner peripheral side of the upper end peripheral portion 23, the upper end peripheral portion of the annular rotating body 20. When the medicine carried on the carriage 23 comes into contact with the discharge guide 13, the medicine may drop toward the inclined rotary body 30 by reaction and may be sandwiched between the annular rotary body 20 and the discharge guide 13. The occurrence is easily prevented.
Although the illustration is omitted because it is a fine shape, in order to easily prevent the medicine from rolling down to the drop discharge port 14 due to inertia before the drug is pushed out to the drop discharge port 14 by the discharge guide 13, the upper end peripheral portion 23 The outermost part of the upper surface is slightly raised.

さらに、図示を割愛したが、回転駆動モータ54の動作制御を担うコントローラと、それらに動作電力を供給する電源も、同じ筐体に内蔵して又は筐体の外に設けられている。また、落下排出口14における薬剤の落下を検出するフォトセンサ等も付設されており、その検出信号がコントローラや錠剤カウンタへ送信される。
コントローラの回転制御は、低速回転から始まり、最初の薬剤の排出を検出した後、更に、予め設定された所定数の薬剤の排出を検出すると、高速回転に移行するようになっている。また、予め指定された総排出数と排出済み個数とから残数を算出するとともに、やはり指定された所定数に残数が達すると回転速度を落としたり、薬剤排出完了後に不所望な過剰落下の防止のため逆回転を行わせるようにもなっている。
Further, although not shown in the figure, a controller for controlling the operation of the rotary drive motor 54 and a power supply for supplying operating power to them are also provided in the same housing or provided outside the housing. Further, a photo sensor or the like for detecting the drop of the medicine at the drop discharge port 14 is also provided, and the detection signal is transmitted to the controller or the tablet counter.
The rotation control of the controller starts from the low speed rotation, and after detecting the discharge of the first medicine, and further detecting the discharge of a predetermined number of medicines set in advance, shifts to the high speed rotation. In addition, the remaining number is calculated from the total number of ejected and the number of ejected that are specified in advance, and when the remaining number reaches the specified number, the rotation speed is slowed down or an undesired excessive drop occurs after the completion of drug ejection. It is also designed to rotate in reverse for prevention.

このような構成の薬剤フィーダ10について、その動作等を、図面を引用して説明する。図12も、図13も、(a)が平面図で、(b)が縦断正面図であり、それらのうち図12は、回転容器20+30に収容されている薬剤5を上端周縁部23の上に整列させ始めたところを示し、図13は、整列させた薬剤5を上端周縁部23から落下排出口14へ送り込んでいるところを示している。なお、薬剤5は、夫々の置かれた状況に応じて型用薬剤5a,ランダム収容薬剤5b,整列済み薬剤5cと呼ぶこともある。 The operation and the like of the medicine feeder 10 having such a configuration will be described with reference to the drawings. 12 and 13 are (a) a plan view and (b) a vertical front view, in which FIG. 12 shows the drug 5 contained in the rotary container 20+30 on the upper end peripheral portion 23. FIG. 13 shows that the aligned medicines 5 are being fed from the upper end peripheral portion 23 to the drop discharge port 14. The medicines 5 may also be referred to as the mold medicines 5a, the random-accommodating medicines 5b, and the aligned medicines 5c, depending on the respective placed conditions.

薬剤フィーダ10を使用して多数の薬剤5を逐次送出するには(図12参照)、それに先だって、薬剤搬送経路幅の規制作業と薬剤のランダム投入とを済ませておく。
そのうち、薬剤搬送経路幅の規制作業は、作業担当者が、多数の薬剤5のうちから適宜な一個を型用薬剤5aに選出して、それを型置場74に収めてから、それにリンク機構73の一端が当接するようにリンク機構73の位置を調整するという簡単なことで、遂行される。
In order to sequentially deliver a large number of medicines 5 using the medicine feeder 10 (see FIG. 12 ), prior to that, the regulation work of the medicine conveyance route width and the random introduction of the medicines are completed.
Among them, in the work of regulating the width of the medicine transport path, the worker selects an appropriate one from the large number of medicines 5 as the mold medicine 5a, stores it in the mold storage 74, and then links it to the mold 73. This is accomplished simply by adjusting the position of the link mechanism 73 so that one end of the contact point abuts.

その作業が行われると、第1規制部材71と第2規制部材72とが何れもリンク機構73に連動して揺動し、それらの揺動端部によって環状回転体20の上端周縁部23の上の薬剤搬送経路幅が二カ所で型用薬剤5aの直径に対応するところまで狭められる。
また、薬剤のランダム投入は、やはり作業担当者が、文字通り多数の薬剤5を環状回転体20の上部開口から回転容器20+30へランダムに投入すれば良い。
そうすると、投入されたランダム収容薬剤5bは、自然に、傾斜回転体30の上面のうち下側に来ている部分の上に集まる。
When the work is performed, both the first restricting member 71 and the second restricting member 72 swing together with the link mechanism 73, and the swinging end portions of the upper end peripheral portion 23 of the annular rotary body 20. The width of the upper drug delivery path is narrowed to two places corresponding to the diameter of the mold drug 5a.
In addition, as for the random injection of the medicines, the operator may just randomly insert a large number of the medicines 5 into the rotary container 20+30 from the upper opening of the annular rotary body 20.
Then, the introduced random-containing medicine 5b naturally collects on the lower part of the upper surface of the tilted rotating body 30.

これで自動動作の準備が調うので、薬剤フィーダ10を例えば単純な連続送出モード等で動作させると、以後はコントローラの制御に従って回転駆動モータ54が適宜な速度で回転する。そうすると、それに応じて回転駆動部材51が軸回転し、その回転運動が、大径部外装回転伝動部材42を介した摩擦伝動にて環状回転体20に伝達されるとともに、小径部外装回転伝動部材43を介した摩擦伝動にて傾斜回転体30にも伝達されて、大径部外装回転伝動部材42と小径部外装回転伝動部材43とが同じ向きに軸回転するが、大径部外装回転伝動部材42の方が小径部外装回転伝動部材43より高速で回転する。 With this, the preparation for automatic operation is completed, and when the medicine feeder 10 is operated in a simple continuous feeding mode or the like, thereafter, the rotation drive motor 54 rotates at an appropriate speed under the control of the controller. As a result, the rotary drive member 51 is axially rotated accordingly, and the rotational movement is transmitted to the annular rotary body 20 by frictional transmission via the large-diameter portion exterior rotation transmission member 42 and the small-diameter portion exterior rotation transmission member. The large-diameter portion exterior rotation transmission member 42 and the small-diameter portion exterior rotation transmission member 43 are axially rotated in the same direction by being transmitted to the inclined rotating body 30 by friction transmission via the large-diameter portion exterior rotation transmission 43. The member 42 rotates faster than the small-diameter portion exterior rotation transmission member 43.

傾斜回転体30が軸回転すると、回転容器20+30の内底に溜まっていたランダム収容薬剤5bのうち傾斜回転体30の周縁部33の上に来ていた薬剤5が、鋸歯状の周縁部33の循環運動によって低位置から高位置へ掬い上げられる。
そうして、周縁部33が環状回転体20の上端周縁部23よりも高くなるところまで運ばれた薬剤5は、大部分が周縁部33の傾斜に基づく滑落や転動によって上端周縁部23の上へ乗り移る。
When the tilted rotary body 30 rotates about the axis, the medicine 5 that has come on the peripheral edge portion 33 of the tilted rotary body 30 out of the random containing medicines 5b accumulated in the inner bottom of the rotary container 20+30 is transferred to the serrated peripheral edge portion 33. It is scooped up from a low position to a high position by circulatory movement.
Then, most of the medicine 5 carried to the position where the peripheral edge portion 33 is higher than the upper end peripheral edge portion 23 of the annular rotating body 20 is slid or rolled due to the inclination of the peripheral edge portion 33 so that the upper end peripheral edge portion 23 of the pharmaceutical agent 5 is removed. Transfer to the top.

これに対し、上端周縁部23の上が先行の他の薬剤5で詰まっていたり、たまたま滑落や転動しなかったといった理由で、傾斜回転体30の周縁部33の上に残っていた薬剤5は、傾斜回転体30の更なる軸回転によって仕分け部材60の先端部62の所へ運ばれ、そこで先端部62に当接し、その当接の反動によって上端周縁部23とは逆の向きに移動させられるため、傾斜回転体30の央部32を傾斜面に沿って滑落する。
こうして、過剰な薬剤5等がランダム収容薬剤5bに戻るので、上端周縁部23の上の薬剤搬送経路には或る程度絞り込まれて適量に近い頻度で薬剤5が送り込まれる。
On the other hand, the drug 5 remaining on the peripheral edge portion 33 of the inclined rotary body 30 because the upper peripheral edge portion 23 is clogged with the preceding other chemical agent 5 or does not happen to slip off or roll. Is conveyed to the tip portion 62 of the sorting member 60 by the further axial rotation of the tilting rotary body 30, and abuts on the tip portion 62 there, and is moved in the direction opposite to the upper end peripheral portion 23 by the reaction of the abutment. Therefore, the central portion 32 of the inclined rotating body 30 slides down along the inclined surface.
In this way, since the excessive drug 5 and the like return to the randomly stored drug 5b, the drug 5 is sent to the drug delivery path above the upper end peripheral portion 23 to a certain extent, and the drug 5 is delivered at a frequency close to an appropriate amount.

環状回転体20の方が傾斜回転体30より高速で軸回転しているので、上端周縁部23の上の薬剤5は、周縁部33から乗り移ったときに回転速度の差に応じて或る程度はばらけるが、薬剤5が小さめの場合など、縦一列になるものもあれば、真横や斜め横に並ぶものもありうる。そして、それらの薬剤5が、環状回転体20の軸回転によって第1規制部材71の所へ運ばれると、一列の薬剤5はそのまま通過するが、横並びの薬剤5については第1規制部材71との干渉によって内側の薬剤5が上端周縁部23の上から押し出されて傾斜回転体30の上に落下しランダム収容薬剤5bに戻るので、横並びが解消される。 Since the annular rotating body 20 is rotating at a higher speed than the inclined rotating body 30, the medicine 5 on the upper end peripheral portion 23 is transferred to the peripheral portion 33 from the peripheral portion 33 to a certain extent according to the difference in rotational speed. Although they are separated, some of them may be vertically aligned, such as when the medicines 5 are small, and others may be arranged right next to each other or diagonally horizontally. Then, when the medicines 5 are carried to the first restricting member 71 by the axial rotation of the annular rotating body 20, the medicines 5 in one row pass through as they are, but the medicines 5 arranged side by side with the first restricting member 71. Due to the interference of the above, the medicine 5 on the inner side is pushed out from above the upper end peripheral portion 23, falls on the inclined rotating body 30 and returns to the randomly stored medicine 5b, so that the side-by-side arrangement is eliminated.

とはいえ、横並びの薬剤5が多いとき等には、薬剤5同士の押し合い等によって第1規制部材71の先端を巻くようにすり抜ける薬剤5もありうる。そして、そのような場合、第1規制部材71を通過した薬剤5のうち一部のものには斜め横の並び状態が残ったりすることがある。いずれにしろ、第1規制部材71を通過した薬剤5は、その後、環状回転体20の軸回転よって第2規制部材72の所へ運ばれて、再び同様の整列が強制されるため、例え横並び状態が残っていても僅かなものにすぎないうえ程度も斜め横の並びの軽い状態にとどまることから、横並び状態が再度の規制で迅速かつ十分に解消される。 However, when there are many side-by-side medicines 5 and the like, there may be medicines 5 that slip through the tip of the first restricting member 71 by winding the medicines 5 against each other. In such a case, some of the medicines 5 that have passed through the first restricting member 71 may remain in a diagonally lateral arrangement state. In any case, the drug 5 that has passed through the first restricting member 71 is then carried to the position of the second restricting member 72 by the axial rotation of the annular rotating body 20, and the similar alignment is forced again. Even if the state remains, it is only a slight amount, and the degree of diagonal sideways is still light, so that the side-by-side state is quickly and sufficiently resolved by re-regulation.

このようにして二重の規制をクリアして一列に整列した整列済み薬剤5cは(図13参照)、環状回転体20の軸回転に伴う上端周縁部23の循環運動によって次々に排出ガイド13の所へ運ばれ、上端周縁部23の上の薬剤搬送経路と斜めに交差している排出ガイド13の外側側面に当接する。
そして、整列済み薬剤5cの多くは、直ちに排出ガイド13の当接側面に沿って進み、一列になって落下排出口14に送り込まれる。
In this way, the aligned medicines 5c that have passed the double regulation and are aligned in a line (see FIG. 13) are sequentially moved by the circulation motion of the upper end peripheral portion 23 due to the axial rotation of the annular rotating body 20 of the discharge guide 13. When it is carried to a place, it comes into contact with the outer side surface of the discharge guide 13 that obliquely intersects with the medicine transport path on the upper edge portion 23.
Then, most of the aligned medicines 5c immediately advance along the contact side surface of the discharge guide 13 and are fed into the drop discharge port 14 in a line.

もっとも、当接状況によっては希に一部の整列済み薬剤5cが内周側へ少しはじかれることもあるが、そのような状況が生じたときでも、整列済み薬剤5cの環状回転体20の上への落下や、上端周縁部23と排出ガイド13との斜交部位への挟み込みは、搬送面ガイド12によって阻止される。
こうして、総ての整列済み薬剤5cが無駄なく一列で落下排出口14に送り込まれる。落下排出口14に送り込まれた薬剤5は重力で加速されて落下速度を増すことから、先後の薬剤5の離隔距離が広がるので、その離隔距離が十分になる所に設置したフォトセンサ等で落下薬剤5を検出するといったことで、的確に、薬剤5を計数することができる。
However, depending on the contact situation, a part of the aligned medicines 5c may be slightly repelled toward the inner peripheral side, but even when such a situation occurs, the aligned medicines 5c on the annular rotator 20 are aligned. The conveyance surface guide 12 prevents the upper end peripheral portion 23 and the discharge guide 13 from being caught in the oblique intersection.
In this way, all the aligned chemicals 5c are fed into the drop discharge port 14 in a row without waste. The medicine 5 sent to the drop discharge port 14 is accelerated by gravity to increase the falling speed, so that the separation distance of the medicine 5 before and after is widened, and the medicine 5 is dropped by a photosensor or the like installed in a place where the separation distance is sufficient. By detecting the drug 5, the drug 5 can be accurately counted.

そして、そのような薬剤5の整列と排出とを繰り返して大量の薬剤5の処理が完了したときや、薬剤5の種類が切り替わることになったときなど、薬剤フィーダ10の動作を止めるのに加えて、しばしば回転容器20+30を清掃することも必要になるが、その場合、先ず最上部の周壁11等を取り外してから、例えば傾斜回転体30の中央突起31を手掛かりにして、傾斜回転体30を持ち上げると、回転容器20+30が纏まって筐体から抜け出す。回転容器20+30は、支承機構40によて支承されているだけなので、簡単に取り出すことができ、丸洗い等で手軽に清掃されて綺麗になる。こうして、使用後の清掃を容易かつ迅速に済ませられるので後は逆順の作業で元に戻して次の使用に備える。 In addition to stopping the operation of the drug feeder 10 when the processing of a large amount of drugs 5 is completed by repeating such alignment and discharge of the drugs 5 or when the type of the drugs 5 is switched, Therefore, it is often necessary to clean the rotary container 20+30. In that case, first remove the uppermost peripheral wall 11 and the like, and then use the central projection 31 of the tilted rotary body 30 as a clue to move the tilted rotary body 30. When lifted, the rotating containers 20+30 collectively come out of the housing. Since the rotary container 20+30 is only supported by the support mechanism 40, it can be easily taken out and cleaned easily by cleaning with a circle or the like. In this way, cleaning after use can be completed easily and promptly, and thereafter the work is returned in reverse order to prepare for the next use.

特開2018−108277号公報JP, 2018-108277, A

このような薬剤フィーダにあっては、二重回転タイプ薬剤フィーダを基本にしたことにより、すなわち、回転容器を内外二重化してそれらの回転にて内側の傾斜回転体から外側の環状回転体の上端周縁部の上に固形薬剤を運び更にその固形薬剤を規制部材にて整列させるようにしたことにより、回転体の中に固定の整流ガイドを設ける必要が無くなったばかりか、薬剤幅等の規制可能タイプのうちでは薬剤収容量が多く、さらには種々の形状やサイズの薬剤に対する共用範囲が広がっている。 In such a drug feeder, a double-rotation type drug feeder is used as a base, that is, the rotating container is doubled inside and outside, and the upper and lower ends of the annular rotating body on the outside from the inclined rotating body on the inside by rotating them. By transporting the solid drug on the peripheral edge and aligning the solid drug with the regulating member, not only does it not need to provide a fixed flow guide in the rotating body, but also the type that can regulate the drug width, etc. Among them, the drug storage amount is large, and further, the shared range for drugs of various shapes and sizes is expanding.

そして、そのような共用範囲の広がりの一環として、円板形や円盤状といった比較的安定した形状の錠剤ばかりでなく、球状や紡錘状といった転がり易い形状の薬剤(以下、転動容易な薬剤とも呼ぶ)についても、共用の要望が高まってきた。
ところが、転動容易な薬剤は、傾斜回転体から環状回転体へ乗り移ったときや、環状回転体が回転したときなどに、環状回転体の上で転がって位置や姿勢が安定しないことが多く、その共用化には薬剤フィーダの薬剤整列機能強化の一環として薬剤の転動抑止機能の追加や強化も必要になる。
And as part of the expansion of such a common range, not only tablets with a relatively stable shape such as a disk shape or a disk shape, but also a medicine with a rollable shape such as a spherical shape or a spindle shape (hereinafter, also referred to as a drug that easily rolls The demand for sharing has also increased.
However, a drug that easily rolls often rolls on the ring-shaped rotary body and the position and posture are not stable when it is transferred from the inclined rotary body to the ring-shaped rotary body, or when the ring-shaped rotary body rotates. In order to make it common, it is necessary to add or enhance the roll prevention function of the drug as part of strengthening the drug alignment function of the drug feeder.

そして、そのような機能強化には、薬剤整列機能を担う既述の仕分け部材60や規制機構70を増強することが思い浮かぶ。
しかしながら、それらの装備箇所には既に多くの部材が配設されており、転動抑止機能のためだけに新たな部材を追加するは負担が重い。
そこで、二重回転タイプ薬剤フィーダを踏襲しつつ環状回転体の改良にて転動容易な薬剤までも能率良く送り出せる薬剤フィーダを実現することが技術的な課題となる。
Then, in order to enhance the function, it is conceivable to enhance the already-described sorting member 60 and the regulation mechanism 70 that have the drug alignment function.
However, many members have already been arranged at those equipment locations, and it is burdensome to add a new member only for the rolling restraint function.
Therefore, it is a technical subject to realize a drug feeder that can efficiently deliver even a drug that easily rolls by improving the annular rotating body while following the double rotation type drug feeder.

本発明の薬剤フィーダは(解決手段1)、このような課題を解決するために創案されたものであり、縦線を中心として軸回転可能な外側の環状回転体と、前記縦線から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる規制部材とを備えた薬剤フィーダであって、前記環状回転体は、その前記上端周縁部に、径方向に延びており且つ径方向の途中で拡幅している溝が周方向に列設されている、ことを特徴とする。
なお、上記の縦線は、仮想のものであり、既述した鉛直線が典型的であるが、環状回転体の薬剤移送機能を損なわないほど少しなら鉛直線から傾いていても良い。
The medicine feeder of the present invention (Solution 1) was created to solve such a problem, and has an outer ring-shaped rotating body that is axially rotatable about a vertical line and is inclined from the vertical line. An inclined rotary body that is mounted inside the annular rotary body so as to be axially rotatable about an inclined line and closes the hollow of the annular rotary body, and an upper end of the annular rotary body from above by the rotation of the inclined rotary body. A drug feeder comprising: a regulating member for aligning a solid drug carried on a peripheral edge portion when the annular rotary member is rotated, wherein the annular rotary member extends in a radial direction at the upper end peripheral edge portion thereof. And grooves that are wide in the radial direction are arranged in a row in the circumferential direction.
The vertical line is a virtual line and is typically the vertical line described above, but it may be inclined from the vertical line as long as it does not impair the drug transfer function of the annular rotating body.

また、本発明の薬剤フィーダは(解決手段2)、上記解決手段1の薬剤フィーダであって、前記環状回転体の前記上端周縁部の外周部分が一周に亘って面取りされており、その面取にまで前記溝が達していることを特徴とする。 Further, the medicine feeder of the present invention is (Solution Means 2), which is the medicine feeder of the above Means for Solving 1, wherein the outer peripheral portion of the upper end peripheral portion of the annular rotary member is chamfered over one round, and the chamfering thereof is performed. It is characterized in that the groove reaches up to.

さらに、本発明の薬剤フィーダは(解決手段3)、上記解決手段2の薬剤フィーダであって、前記環状回転体の前記上端周縁部の上の薬剤を内周側から外周側へ導いて落下排出口へ送り込む排出ガイドが設けられており、前記縦線が鉛直線から傾斜しており、その傾斜方向が前記環状回転体のうち前記落下排出口寄りの部位を高める向きになっており、前記傾斜の程度が前記面取の傾きより小さいことを特徴とする。 Further, the drug feeder of the present invention (solution means 3) is the drug feeder of the solution means 2, wherein the drug on the upper end peripheral portion of the annular rotating body is guided from the inner peripheral side to the outer peripheral side and dropped and discharged. A discharge guide for feeding to the outlet is provided, and the vertical line is inclined from a vertical line, and the inclination direction is a direction in which a portion of the annular rotating body near the drop discharge outlet is raised. Is smaller than the inclination of the chamfer.

また、本発明の薬剤フィーダは(解決手段4)、上記解決手段1〜3の薬剤フィーダであって、前記傾斜回転体および前記環状回転体を回転させる回転駆動機構が前記傾斜回転体の回転方向と前記環状回転体の回転方向とを個別に反転しうるものであることを特徴とする。 Further, the medicine feeder of the present invention is (solution means 4), which is the medicine feeder of the above-mentioned solution means 1 to 3, wherein a rotation drive mechanism for rotating the tilt rotating body and the annular rotating body has a rotation direction of the tilt rotating body. And the rotation direction of the annular rotating body can be individually reversed.

このような本発明の薬剤フィーダにあっては(解決手段1)、二重回転タイプ薬剤フィーダを基本にして、更に、環状回転体の上端周縁部に多数の溝を形成し、それらの溝の並び方については周方向に列なるようにし、それぞれの溝については径方向に延びた状態にするとともに径方向の途中で溝幅が広がるようにしたことにより、転動容易な薬剤が環状回転体の上で転がると特に環状回転体の回転によって環状回転体の周方向へ転がるとその移動時に近くの溝に捕まり、それから溝によって溝幅の狭い所から溝幅の広い所へ導かれ、そこに落ち着く。 In such a medicine feeder of the present invention (Solution 1), based on the double rotation type medicine feeder, a large number of grooves are further formed in the upper end peripheral portion of the annular rotating body, and those grooves are formed. The arrangement is arranged in the circumferential direction, and the grooves are extended in the radial direction and the groove width is widened in the middle of the radial direction. When rolling over, especially when rolling in the circumferential direction of the annular rotating body due to rotation of the annular rotating body, it is caught in a nearby groove at the time of movement, and then it is guided by the groove from a narrow groove to a wide groove and settles there. ..

そのため転動容易な薬剤に対する転動抑止機能が強化されるが、その強化手段が環状回転体の上端周縁部に対して特定形状の溝を周方向へ列設することで具現化されるので、仕分け部材や規制機構の配設箇所やその近傍に部材を追加するまでもなく容易に所望の転動抑止機能が発揮されることになる。
従って、本発明によれば、二重回転タイプ薬剤フィーダを踏襲しつつ環状回転体の改良にて転動容易な薬剤までも能率良く送り出せる薬剤フィーダを実現することができる。
Therefore, the rolling restraining function for a drug that easily rolls is strengthened, but since the strengthening means is embodied by arranging a groove of a specific shape in the circumferential direction with respect to the upper end peripheral portion of the annular rotating body, The desired rolling suppression function can be easily exerted without adding a member to the place where the sorting member or the regulating mechanism is provided or in the vicinity thereof.
Therefore, according to the present invention, it is possible to realize a drug feeder that follows the double-rotation type drug feeder and improves the annular rotary member to efficiently deliver even a drug that is easily rolled.

また、本発明の薬剤フィーダにあっては(解決手段2)、環状回転体の上端周縁部の外周部分に対して一周に亘って面取を形成するとともに、その面取に薬剤整列機能(薬剤転動抑止機能)強化用の溝が達するようにもしたことにより、環状回転体の上の薬剤を排出ガイド等で外周方向へ付勢したときに、溝の所で落ち着いていた薬剤が溝から外れると直ぐに面取の傾斜によって加速されるので、環状回転体の上で薬剤転動を抑制しても、環状回転体から外周方向への薬剤送出は円滑かつ迅速になされることになる。 Further, in the medicine feeder of the present invention (Solution Means 2), a chamfer is formed over the outer peripheral portion of the upper end peripheral portion of the annular rotary member over the entire circumference, and the chamfer has a medicine aligning function (medicine). (Rolling suppression function) By making the strengthening groove reach, when the drug on the annular rotating body is urged in the outer peripheral direction by a discharge guide, etc., the drug that has settled in the groove is removed from the groove. Immediately after it is disengaged, it is accelerated by the inclination of the chamfer, so that even if the rolling of the drug is suppressed on the annular rotating body, the drug can be smoothly and quickly delivered from the annular rotating body to the outer peripheral direction.

さらに、本発明の薬剤フィーダにあっては(解決手段3)、落下排出口寄りの部位を高める向きに少しだけ環状回転体を傾けたことにより、落下を間近に控えて搬送されている薬剤が、環状回転体の傾きに起因する付勢によって、落下排出口の方から排出ガイドの方へ寄せられるので、過剰な転動等によって薬剤が予定より早く落下排出口へ行ってしまうといった不所望な事態の発生が、簡便だが的確に抑制される。
しかも、環状回転体全体の傾斜ひいては上端周縁部の傾斜は、環状回転体の上端周縁部の外周部分の面取の傾きより小さいので、面取の付勢機能は、損なわれることなく、維持される。
Further, in the medicine feeder of the present invention (Solution Means 3), since the annular rotating body is slightly tilted in the direction to raise the portion near the drop discharge port, the medicine that is being conveyed while the drop is imminent is conveyed. Since the force due to the inclination of the annular rotating body causes the drop discharge port to move closer to the discharge guide, excessive rolling or the like causes the medicine to go to the drop discharge port earlier than expected. Occurrence of a situation is simple but appropriately suppressed.
Moreover, since the inclination of the entire annular rotating body and thus the inclination of the upper end peripheral portion is smaller than the inclination of the chamfering of the outer peripheral portion of the upper end peripheral portion of the annular rotating body, the biasing function of the chamfer is maintained without being impaired. It

また、本発明の薬剤フィーダにあっては(解決手段4)、傾斜回転体の反転と環状回転体の反転とが個別に行えるようにしたことにより、環状回転体を正転させながら傾斜回転体を逆転させることが出来るため、環状回転体による薬剤搬送の速度を落すことなく、傾斜回転体の正転だけでは得られない撹拌効果を傾斜回転体の逆転によって得ることができる。 Further, in the medicine feeder of the present invention (Solution 4), since the tilted rotary body and the annular rotary body can be reversed individually, the tilted rotary body can be rotated in the forward direction. Since it is possible to reverse the rotation, the stirring effect which cannot be obtained only by the normal rotation of the tilted rotary body can be obtained by the reverse rotation of the tilted rotary body without reducing the speed of drug delivery by the annular rotary body.

薬剤フィーダの傾斜回転体の構造を示し(a)がその丸板部の三面図、(b)が傾斜回転体の外観斜視図である。The structure of the inclination rotator of a medicine feeder is shown, (a) is a three-view figure of the round plate part, (b) is an external appearance perspective view of an inclination rotator. 薬剤フィーダの環状回転体の構造を示し、(a)が全体の縦断面図、(b)がその一部の拡大図、(c)が上部の縦断面図である。The structure of the annular rotary body of a medicine feeder is shown, (a) is the whole longitudinal cross-sectional view, (b) is an enlarged view of a part thereof, (c) is a vertical cross-sectional view of the upper part. (a)が環状回転体の上端周縁部の平面図、(b)がその一部の拡大図である。(A) is a top view of the upper end peripheral part of an annular rotary body, (b) is the one part enlarged view. 薬剤フィーダの規制機構の構造を示し、(a)が大きめの型用薬剤を型置場に置いたときの平面図、(b)が小さめの型用薬剤を型置場に置いたときの平面図、(c)が第1,第2規制部材に係る平面図と正面図と底面図と端面図である。The structure of the regulation mechanism of a drug feeder is shown, (a) is a plan view when a large mold drug is placed in a mold place, (b) is a plan view when a smaller mold drug is placed in a mold place, (C) is a top view, a front view, a bottom view, and an end view of the first and second regulating members. 薬剤フィーダの仕分け機構の構造を示し、(a)が仕分け機構とその設置先部分との斜視図、(b)が第1仕分け部材の正面図、(c)が第2仕分け部材の正面図である。The structure of the sorting mechanism of a drug feeder is shown, (a) is a perspective view of a sorting mechanism and its installation destination part, (b) is a front view of a 1st sorting member, (c) is a front view of a 2nd sorting member. is there. 薬剤フィーダの容器延伸体の構造を示し、(a)が斜視図、(b)が底面図、(c)が側面図である。The structure of the container extending|stretching body of a chemical|medical agent feeder is shown, (a) is a perspective view, (b) is a bottom view, (c) is a side view. 薬剤フィーダに全体構造を示し、(a)が大蓋を開けた状態の観斜視図、(b)が大蓋を閉じた状態の外観斜視図である。The whole structure is shown in a medicine feeder, (a) is a perspective view with a large lid open, and (b) is an external perspective view with the large lid closed. (a)が薬剤フィーダ内部の機械構造を示し、(b)が制御部のブロック構成図である。(A) shows the mechanical structure inside a medicine feeder, (b) is a block block diagram of a control part. 背景技術欄で述べた従来の薬剤フィーダについて、全体の構造を示し、(a)が平面図、(b)が縦断正面図である。About the conventional chemical|medical agent feeder described in the background art column, the whole structure is shown, (a) is a top view, (b) is a longitudinal front view. その従来の薬剤フィーダに係り、(a)がリンク機構や周壁上層部を取り外したところの平面図、(b)が周壁も取り外したところの平面図である。FIG. 10A is a plan view showing the conventional medicine feeder with the link mechanism and the peripheral wall upper layer portion removed, and FIG. 14B is a plan view with the peripheral wall also removed. その従来の薬剤フィーダに係り、(a)が仕分け部材の正面図と右側面図と右側面図であり、(b)がフィーダ要部の展開図であって周壁等と回転容器は縦断面を図示し回転駆動機構と回転伝動部材は外観を図示している。Regarding the conventional drug feeder, (a) is a front view, a right side view and a right side view of a sorting member, (b) is a development view of a feeder main part, and a peripheral wall etc. and a rotary container are vertical cross sections. The rotation drive mechanism and the rotation transmission member are shown in appearance. その従来の薬剤フィーダについて、収容した薬剤を整列させ始めたところの動作状態を示し、(a)が平面図、(b)が縦断正面図である。About the conventional medicine feeder, the operation|movement state when starting to arrange the accommodated medicine is shown, (a) is a top view and (b) is a longitudinal front view. その従来の薬剤フィーダについて、整列させた薬剤を落下排出口へ送り出しているところの動作状態を示し、(a)が平面図、(b)が縦断正面図である。About the conventional medicine feeder, the operation state in which the aligned medicines are sent out to the drop discharge port is shown, (a) is a plan view and (b) is a longitudinal front view.

このような本発明の薬剤フィーダについて、これを実施するための具体的な形態を、以下の実施例1により説明する。
図1〜図8に示した実施例1は、上述した解決手段1〜4(出願当初の請求項1〜4)を総て具現化したものである。
なお、それらの図示に際しては、簡明化等のため、筐体パネルや,ボルト等の締結具,ヒンジ等の連結具,モータドライバ等の電気回路,コントローラ等の電子回路などは図示を割愛し、発明の説明に必要なものや関連するものを中心に図示した。
With respect to such a drug feeder of the present invention, a specific mode for carrying out the present invention will be described with reference to Example 1 below.
The first embodiment shown in FIGS. 1 to 8 embodies all of the above-mentioned solving means 1 to 4 (claims 1 to 4 at the time of application).
In order to simplify the drawings, illustrations of the housing panel, fasteners such as bolts, connectors such as hinges, electric circuits such as motor drivers, electronic circuits such as controllers, etc. are omitted for simplicity. The drawings are mainly shown for those necessary for explaining the invention and related matters.

本発明の薬剤フィーダの実施例1について、その具体的な構成を、図面を引用して説明する。実施例1の薬剤フィーダ100の全体構成は(図7,図8参照)、既述した薬剤フィーダ10の全体構成を概ね踏襲しており(図9参照)、周壁11や,搬送面ガイド12,排出ガイド13,落下排出口14,支承機構40,それらを載置又は収容した筐体,更には全体的な部材配置などは、ほぼ既述品と同様のもので足りるので、繰り返しとなる説明は割愛する。 A specific configuration of the first embodiment of the medicine feeder of the present invention will be described with reference to the drawings. The overall configuration of the drug feeder 100 according to the first embodiment (see FIGS. 7 and 8) substantially follows the overall configuration of the drug feeder 10 described above (see FIG. 9 ), and the peripheral wall 11, the transport surface guide 12, The discharge guide 13, the drop discharge port 14, the support mechanism 40, the housing on which they are placed or accommodated, and the overall member arrangement are substantially the same as those described above, and thus the repeated description will be omitted. Omit.

また、既述した環状回転体20や,傾斜回転体30,回転駆動機構50,仕分け部材60,規制機構70は(図9〜図11参照)、それぞれ、改造されて、新たな環状回転体200,傾斜回転体300,回転駆動機構500,仕分け機構600,規制機構700になっているので(図1〜図8参照)、各部について既述品と異なる改造点を中心に詳述する。なお、それに随伴して二重回転タイプの回転容器20+30は二重回転タイプの回転容器200+300になっている。さらに、容器延伸体800と大蓋110が(図7参照)、新たに追加されているので、それらについても説明する。 Further, the annular rotating body 20, the inclined rotating body 30, the rotation driving mechanism 50, the sorting member 60, and the restricting mechanism 70 (see FIGS. 9 to 11) described above are respectively modified to provide a new annular rotating body 200. , The inclined rotary body 300, the rotary drive mechanism 500, the sorting mechanism 600, and the regulating mechanism 700 (see FIGS. 1 to 8), each part will be described in detail focusing on the modification points different from the already described products. Incidentally, the double-rotation type rotary container 20+30 is accompanied by the double-rotation type rotary container 200+300. Furthermore, since the container extending body 800 and the large lid 110 (see FIG. 7) are newly added, they will also be described.

図1に示した傾斜回転体300は、既述の傾斜回転体30を改造したものである。図1は、薬剤フィーダ100の回転容器200+300の傾斜回転体300の構造を示しており、(a)が傾斜回転体300の要部の丸板部310の三面図にあたる側面図(AA断面)と平面図(B矢視)と正面図(C矢視)とであり、(b)が傾斜回転体300の外観斜視図である。
傾斜回転体300は、概ね円盤状の丸板部310を主体としたものであり(図1(a)参照)、上面中央に既述の中央突起31を維持するとともに(図1(b)参照)、下面の中央から下方へ突き出た回転軸部370を具備している(図1(b)参照)。
The tilting rotary body 300 shown in FIG. 1 is a modification of the tilting rotary body 30 described above. FIG. 1 shows the structure of the tilted rotary body 300 of the rotary container 200+300 of the medicine feeder 100. FIG. 1A is a side view (AA cross section) corresponding to a three-sided view of a round plate portion 310 of a main part of the tilted rotary body 300. It is a plan view (viewed by the arrow B) and a front view (viewed by the arrow C), and (b) is an external perspective view of the inclined rotating body 300.
The inclined rotary body 300 is mainly composed of a substantially disk-shaped round plate portion 310 (see FIG. 1A), and maintains the above-described central protrusion 31 at the center of the upper surface (see FIG. 1B). ), a rotary shaft portion 370 protruding downward from the center of the lower surface (see FIG. 1B).

丸板部310は(図1(a)参照)、中央突起31の周りの上面央部320が概ね平坦になっている。この上面央部320は、既述した傾斜回転体30の央部32のように上面周縁部330より凹ませても良いが、この例では、新規形状部分の強度や加工等を考慮して概ね平坦になっている。
この上面央部320の表面には、概ね径方向に延びる細くて浅い直線状の溝を多数並べて彫ることで並行波状凹凸321が形成されており(図では周方向を異にする3箇所)、斜面で薬剤の転動を促す機能が強化されているので、薬剤の撹拌効果や上面周縁部330への誘導効果が発揮される。
In the round plate portion 310 (see FIG. 1A), the upper surface central portion 320 around the central protrusion 31 is substantially flat. The upper surface central portion 320 may be recessed from the upper surface peripheral portion 330 like the central portion 32 of the tilted rotating body 30 described above, but in this example, the upper surface central portion 320 is generally formed in consideration of the strength and processing of the newly shaped portion. It is flat.
On the surface of the central portion 320 of the upper surface, parallel wavy irregularities 321 are formed by arranging a number of thin and shallow linear grooves extending in the radial direction side by side (three locations having different circumferential directions in the figure). Since the function of promoting the rolling of the medicine on the slope is enhanced, the effect of stirring the medicine and the effect of guiding the medicine to the upper peripheral portion 330 are exhibited.

また、丸板部310は(図1参照)、その上面のうち上面央部320を一周する上面周縁部330に、引渡部340と押上部350とが形成されている。引渡部340と押上部350は周方向で交互に形成されている(図では周方向を異にする6箇所ずつ)。
引渡部340は、取扱対象の薬剤より大きめの局所的な面取状の外下がり切欠であり、その外下がり角度が、概ね45゜程度で、概ね20゜〜30゜程度である傾斜回転体300の装着時傾斜角より大きい。そのため、傾斜回転体300が環状回転体200の中に傾斜状態で装着されても、その状態で軸回転したときに引渡部340の傾斜が水平に対して最も近づく上昇位置でも、引渡部340の外下がり角度は概ね15゜以上を維持する。このような引渡部340にも上記の並行波状凹凸321と同様の模様が形成されている。
In addition, the round plate portion 310 (see FIG. 1) has a transfer portion 340 and a push-up portion 350 formed on an upper surface peripheral portion 330 of the upper surface that surrounds the upper surface central portion 320. The transfer portions 340 and the push-up portions 350 are alternately formed in the circumferential direction (in the figure, six locations differing in the circumferential direction).
The transfer section 340 is a locally chamfered outer downward cutout that is larger than the medicine to be handled, and the outer downward angle is about 45°, and the inclined rotating body 300 is about 20° to 30°. It is larger than the tilt angle when installed. Therefore, even if the inclined rotary body 300 is mounted in the annular rotary body 200 in an inclined state, even when the inclination of the transfer section 340 is the closest to the horizontal when the shaft is rotated in that state, the transfer section 340 is inclined. The outer downward angle is maintained at 15° or more. A pattern similar to that of the parallel wavy unevenness 321 is also formed on the transfer portion 340.

押上部350は、そのような引渡部340の周方向両端のうち後端側に位置する立ち上がり部分であり、引渡部340のような外下がりが無く、央部延長面351と同じかそれより高いところまで立ち上がっている。立ち上がりが央部延長面351と同じ押上部350と、立ち上がりが央部延長面351を超えて凸部360の基部361の前面にまで続く押上部350とが、周方向で交互に形成されている(図示のものでは周方向を異にする6箇所の引渡部340に対して凸部360と共に交互に配置されている)。
凸部360は、引渡部340の後端側の押上部350を上面央部320より高く上方へ延長する基部361と、その上向きの凸部を引渡部340の内周側まで延伸させた延伸部362とを連ねたものであり、総ての引渡部340及び押上部350に付設しても良いが、この実施例では、一つおきに付設されている。
The push-up portion 350 is a rising portion located on the rear end side of the both ends in the circumferential direction of the transfer portion 340, does not have the outward falling like the transfer portion 340, and is the same as or higher than the central extension surface 351. I'm up to the point. Push-up portions 350 whose rising is the same as the central extension surface 351 and push-up portions 350 whose rising portions continue beyond the central extension surface 351 to the front surface of the base 361 of the convex portion 360 are alternately formed in the circumferential direction. (In the figure, the convex portions 360 are alternately arranged with respect to the six transfer portions 340 having different circumferential directions).
The convex portion 360 includes a base portion 361 that extends upward of the push-up portion 350 on the rear end side of the transfer portion 340 to a position higher than the upper surface central portion 320, and an extending portion that extends the upward convex portion to the inner peripheral side of the transfer portion 340. 362 are connected to each other and may be attached to all of the transfer portions 340 and the push-up portions 350, but in this embodiment, they are attached to every other portion.

図2,図3に示した環状回転体200は、既述の環状回転体20を改造したものである。図2は、薬剤フィーダ100の環状回転体200の構造を示しており、(a)が環状回転体200の全体に係る縦断面図、(b)がその上部220の右端部分を拡大した縦断面図、(c)が傾き状態を明記した環状回転体200の縦断面図である。
また、図3は、(a)が環状回転体200の上端周縁部230に係る平面図、(b)が上端周縁部230の一部に係る拡大図である。
The annular rotating body 200 shown in FIGS. 2 and 3 is a modification of the annular rotating body 20 described above. 2A and 2B show the structure of the annular rotating body 200 of the drug feeder 100. FIG. 2A is a vertical sectional view of the entire annular rotating body 200, and FIG. 2B is an enlarged vertical sectional view of the right end portion of the upper portion 220 thereof. FIG. 6C is a vertical cross-sectional view of the annular rotating body 200 in which the tilted state is specified.
3A is a plan view of the upper end peripheral portion 230 of the annular rotating body 200, and FIG. 3B is an enlarged view of a part of the upper end peripheral portion 230.

環状回転体200は(図2(a)参照)、基本的には既述の環状回転体20の構成を引き継いでいるが、上部220と下部210とが一体化して、椀状体の底を抜いたかのような物になっている。しかも、中空の直径が最上位置の上端周縁部230のところで最大であり、そこから下がるほど中空の直径が小さい、というものになっている。そのため、環状回転体200の中空に対して傾斜回転体300を収めるのも抜き取るのも自在にでき、組立や部品交換を行うのが容易である。上部220の上端周縁部230は(図2(b)参照)、外周側の部分には面取232が一周に亘って形成されている。この面取232の傾斜角度αは、図では強調表示されているが、例えば7゜程度である。 The ring-shaped rotating body 200 (see FIG. 2A) basically inherits the structure of the ring-shaped rotating body 20 described above, but the upper portion 220 and the lower portion 210 are integrated to form the bottom of the bowl-shaped body. It is as if it was pulled out. Moreover, the hollow diameter is the largest at the uppermost peripheral edge portion 230 at the uppermost position, and the hollow diameter becomes smaller as it goes down from there. Therefore, the tilted rotary body 300 can be freely housed or removed with respect to the hollow of the annular rotary body 200, and it is easy to assemble or replace parts. The upper end peripheral portion 230 of the upper portion 220 (see FIG. 2B) has a chamfer 232 formed on the outer peripheral side over the entire circumference. Although the inclination angle α of the chamfer 232 is highlighted in the figure, it is about 7°, for example.

また(図2(c)参照)、上部220ひいては環状回転体200の回転中心軸に相当する縦線201(図では二点鎖線)は、鉛直線(図では一点鎖線)から角度βだけ傾いている。この傾斜角度βは、やはり図では強調表示されているが、薬剤搬送機能を損なわないよう例えば3.5゜程度に抑えられており、上述の傾斜角度αより小さい。
そのため、面取232の水平からの傾きは、上端周縁部230の回転に伴って下降時(図では左方)の最大傾斜(α+β)と上昇時の(図では右方)の最小傾斜(α−β)との間で変動するが、面取232の傾斜角度αが環状回転体200の傾斜角度βより大きいので、常に外周側ほど下さがりの状態が維持されるようになっている。
Further (see FIG. 2C), the vertical line 201 (two-dot chain line in the figure) corresponding to the rotation center axis of the upper part 220 and thus the ring-shaped rotary body 200 is inclined by an angle β from the vertical line (one-dot chain line in the figure). There is. The tilt angle β is also highlighted in the figure, but is suppressed to, for example, about 3.5° so as not to impair the drug transport function, and is smaller than the above-described tilt angle α.
Therefore, the inclination of the chamfer 232 from the horizontal is the maximum inclination (α+β) when descending (to the left in the figure) and the minimum inclination (α to the right) when ascending as the upper edge portion 230 rotates. -Β), but since the inclination angle α of the chamfer 232 is larger than the inclination angle β of the annular rotating body 200, the downward state is always maintained toward the outer peripheral side.

このような縦線201の傾斜(β)の向きは、図示を割愛したが、環状回転体200の上端周縁部230の上面(薬剤搬送経路)の高さ(上下位置)が落下排出口14の近くで高くなる方向になっている。
その傾斜(β)は、薬剤フィーダ10の筐体内における環状回転体200の取り付け方などで個々に具現化しても良いが、傾斜(β)が小さいので、例えば、薬剤フィーダ10の筐体を取り付ける先の棚板等の上面を角度βだけ傾斜させておくといったことで、纏めて簡便に具現化することもできる。
Although the illustration of the direction of the inclination (β) of the vertical line 201 is omitted, the height (upper and lower positions) of the upper surface (medicine conveying path) of the upper end peripheral portion 230 of the annular rotating body 200 is the same as that of the drop discharge port 14. It is getting higher in the vicinity.
The inclination (β) may be embodied individually depending on how to attach the annular rotating body 200 in the housing of the medicine feeder 10, but since the inclination (β) is small, for example, the housing of the medicine feeder 10 is attached. The upper surface of the above shelf plate or the like is inclined by an angle β, so that it can be collectively and simply embodied.

さらに(図3参照)、環状回転体200の上部220の上端周縁部230の上面(薬剤搬送経路)には、溝231が周方向に等ピッチで多数列設されている。
それらの溝231は、何れも、菱形や紡錘形に近い形状の彫り込みからなり、長手方向を径方向に向けていて、径方向の両端で幅が縮み、径方向の途中で幅が拡がっており、拡幅部のところで薬剤が落ち着き易いものとなっている。また(図2(b)参照)、溝231の最深部の深さeは、上述の面取232の深さdよりも深くなっている。さらに(図2(b),図3参照)、溝231の外径寄り端部が面取232にまで及んでいるので、溝231から面取232への薬剤移動が円滑に行われるようにもなっている。
Further (see FIG. 3 ), a large number of grooves 231 are arranged in the circumferential direction at equal pitches on the upper surface (medicine transport path) of the upper end peripheral portion 230 of the upper portion 220 of the annular rotator 200.
Each of these grooves 231 is formed by engraving in a shape close to a diamond shape or a spindle shape, the longitudinal direction is directed in the radial direction, the width is reduced at both ends in the radial direction, and the width is expanded in the middle of the radial direction. The medicine is easily settled at the widened portion. Further (see FIG. 2B), the depth e of the deepest portion of the groove 231 is deeper than the depth d of the chamfer 232 described above. Further (see FIG. 2B and FIG. 3), since the outer diameter end of the groove 231 extends to the chamfer 232, the medicine can be smoothly moved from the groove 231 to the chamfer 232. Has become.

また(図2(b),図3参照)、上端周縁部230の上面のうち内周部分には多数の彫り込み233も形成されている。彫り込み233は、何れも、隣り合う溝231,231の間に位置していて、内周寄りほど深い湾状の形をしており、溝231に収まることなく規制機構700等に内周側へ寄せられた転がり易い薬剤を速やかに環状回転体200の薬剤搬送経路から内側の傾斜回転体300の上へ戻すのに役立っている。
これらの溝231や面取232さらに彫り込み233は、薬剤の移動を阻害しないように、円滑面になっているが、上端周縁部230のうち溝231や面取232を除いた上面部分は、薬剤の滑り過ぎを防止するために、ブラスト加工などが施されて、粗面になっている。
Further (see FIGS. 2B and 3), a large number of engravings 233 are also formed on the inner peripheral portion of the upper surface of the upper end peripheral portion 230. Each of the engravings 233 is located between the adjacent grooves 231 and 231 and has a bay-like shape that is deeper toward the inner circumference. This is useful for promptly returning the rolled and easily rolled medicine from the medicine conveying path of the annular rotary body 200 to the upper inside of the inclined rotary body 300.
The groove 231 and the chamfer 232 and the engraving 233 are smooth surfaces so as not to hinder the movement of the medicine, but the upper surface part of the upper end peripheral portion 230 excluding the groove 231 and the chamfer 232 is the medicine. In order to prevent excessive slippage, the surface is roughened by blasting.

図4に示した規制機構700は、既述の規制機構70を改造したものである。図4は、薬剤フィーダ100の規制機構700の構造を示しており、(a)が大きめの型用薬剤5aを型置場740に置いたときの規制機構700に係る平面図、(b)が小さめの型用薬剤5aを型置場740に置いたときの規制機構700に係る平面図である。また、同図(c)は、第1規制部材710と第2規制部材720の何れにも係る図面であり、上段部分が平面図と端面図、中段部分が正面図、下段部分が底面図と端面図である。 The restriction mechanism 700 shown in FIG. 4 is a modification of the restriction mechanism 70 described above. FIG. 4 shows the structure of the regulation mechanism 700 of the medicine feeder 100. (a) is a plan view of the regulation mechanism 700 when a large-sized mold medicine 5a is placed in the mold place 740, and (b) is small. FIG. 7 is a plan view of the regulation mechanism 700 when the mold medicine 5a of FIG. Further, FIG. 6C is a drawing relating to both the first restricting member 710 and the second restricting member 720. The upper part is a plan view and an end view, the middle part is a front view, and the lower part is a bottom view. It is an end view.

規制機構700は(図4(a)参照)、既述した規制機構70を引き継ぐに際して、リンク機構73は概ねそのまま引き継いでいるが、第1規制部材71と第2規制部材72と型置場74には改良が施されて、それぞれ第1規制部材710と第2規制部材720と型置場740になっている。
第1,第2規制部材710,720は同形なので、一方710を詳述するが、第1規制部材710は、既述の第1規制部材71と同様、図では左端の揺動中心部が周壁11側に位置し、図では右端の揺動端部が環状回転体200の上端周縁部230の上方に位置し、リンク機構73の長手方向進退に応じて上端周縁部230の上の薬剤搬送経路幅を外周側から狭める横幅規制機能を発揮するものとなっている(図4(a),(b)参照)。
When the regulating mechanism 700 (see FIG. 4A) takes over the already described regulating mechanism 70, the link mechanism 73 takes over as it is, but the first regulating member 71, the second regulating member 72, and the mold storage area 74. Have been improved to become a first restricting member 710, a second restricting member 720, and a mold storage 740, respectively.
Since the first and second regulating members 710 and 720 have the same shape, the one side 710 will be described in detail. However, the first regulating member 710 is similar to the above-mentioned first regulating member 71 in that the swing center portion at the left end in the drawing is the peripheral wall. 11 side, the swing end portion at the right end in the figure is located above the upper end peripheral portion 230 of the annular rotating body 200, and the drug transport path on the upper end peripheral portion 230 in accordance with the longitudinal movement of the link mechanism 73. It has a lateral width regulating function of narrowing the width from the outer peripheral side (see FIGS. 4A and 4B).

第1規制部材710は(図4(c)参照)、内周側面部が改造されており、内周側面部に、既述の第1規制部材71の内周側面部を踏襲していて横幅規制機能を担う下段部分711だけでなく、既述の第1規制部材71には無かった上段部分712も、形成されている。上段部分712は、下段部分711よりも内周側に張り出しており、上段部分712と下段部分711との間は傾斜面になっている。そのため、第1規制部材710は、下段部分711がリンク機構73の状態に応じた厳密な横幅規制機能を行うのに加えて、上段部分712が緩やかな高さ規制を行うものとなる。第2規制部材720も同じである。 The first restricting member 710 (see FIG. 4C) has a modified inner peripheral side surface part, and the inner peripheral side surface part follows the inner peripheral side surface part of the above-described first restricting member 71 and has a lateral width. Not only the lower portion 711 that has the regulation function, but also the upper portion 712 that is not included in the above-described first regulation member 71 is formed. The upper step portion 712 projects to the inner peripheral side of the lower step portion 711, and an inclined surface is formed between the upper step portion 712 and the lower step portion 711. Therefore, in the first restricting member 710, the lower part 711 performs a strict lateral width restricting function according to the state of the link mechanism 73, and the upper part 712 restricts the height gently. The same applies to the second restricting member 720.

また(図4(a)参照)、規制機構700では、型置場74が改造されて型置場740になるとともに、リンク機構73を型置場740に向けて付勢するバネ730が付設されている。リンク機構73の先端を型用薬剤5a(サンプル薬剤)に当接させて止めることで規制部材710,720の揺動端部の下段部分711,712が上端周縁部230上の薬剤搬送経路幅を薬剤一個通過分に狭める機能は型置場740にも引き継がれており、型置場740が型置場74と相違するのは、小蓋741と止めネジ742とが付設されたことである。小蓋741は、開閉可能な蓋であり、透明な部材からなるので、型用薬剤5aの収容や取出の失念等の防止に役立つ。また、止めネジ742は、閉めた小蓋741がバネ730の付勢力では開かないように、小蓋741を止めておくためのものである。 Further (see FIG. 4A), in the regulation mechanism 700, the mold place 74 is modified to become the mold place 740, and a spring 730 for urging the link mechanism 73 toward the mold place 740 is attached. The lower end portions 711 and 712 of the swinging ends of the regulating members 710 and 720 allow the width of the drug transport path on the upper end peripheral portion 230 to be reduced by bringing the tip of the link mechanism 73 into contact with the mold drug 5a (sample drug) and stopping it. The function of narrowing the amount of one medicine passed is also succeeded to the mold storage 740. The mold storage 740 differs from the mold storage 74 in that the small lid 741 and the set screw 742 are attached. The small lid 741 is an openable/closable lid and is made of a transparent member, which is useful for preventing forgetting to store or take out the mold medicine 5a. The set screw 742 is for fixing the small lid 741 so that the closed small lid 741 is not opened by the urging force of the spring 730.

図5に示した仕分け機構600は、既述の仕分け部材60を改造したものであり、図5は、薬剤フィーダ100の仕分け機構600の構造を示しており、(a)が仕分け機構600とその設置先部分とに係る外観斜視図であり、(b)が仕分け機構600の第1仕分け部材610に係る正面図であり、(c)が仕分け機構600の第2仕分け部材620に係る正面図である。 The sorting mechanism 600 shown in FIG. 5 is a modification of the sorting member 60 described above, and FIG. 5 shows the structure of the sorting mechanism 600 of the drug feeder 100. FIG. FIG. 6 is an external perspective view of an installation destination portion, (b) is a front view of a first sorting member 610 of the sorting mechanism 600, and (c) is a front view of a second sorting member 620 of the sorting mechanism 600. is there.

仕分け機構600は(図5(a)参照)、環状回転体200の上端周縁部230の薬剤搬送経路において既述の仕分け部材60と同様に規制機構700の上流に配設された第1仕分け部材610と、仕分け部材60と異なり上記の薬剤搬送経路において規制機構700と並ぶ位置に配設された第2仕分け部材620とを具備しており、それら複数の部材にて多段階で仕分け機能を発揮するものになっている。
何れの部材610,620も、既述の仕分け部材60と同様に、排出ガイド13を含むとともに規制機構700を支持する板体に対して、装着されている。
The sorting mechanism 600 (see FIG. 5A) is a first sorting member disposed upstream of the regulating mechanism 700 in the medicine transport path of the upper end peripheral portion 230 of the annular rotating body 200, similar to the sorting member 60 described above. 610 and a second sorting member 620, which is different from the sorting member 60 and is arranged at a position aligned with the regulating mechanism 700 in the above-mentioned medicine transport path, and the sorting function is demonstrated in multiple stages by these plural members. It is supposed to do.
Both members 610 and 620 are attached to the plate body that includes the discharge guide 13 and supports the regulation mechanism 700, as in the sorting member 60 described above.

第1仕分け部材610は(図5(a),(b)参照)、手動のネジ機構にて上下位置を調整しうる短かめの支持部材611と、その先端寄り部位に取り付けられて支持部材611に随伴して上下する前段垂下物612とを具備している。
前段垂下物612は(図5(b)参照)、複数の大玉613(図では二個の球体)を緩く連結して鎖状にしたものであり、市販のボールチェーン等で足りれば容易かつ安価に具現化できる。第1仕分け部材610では、二個の前段垂下物612が、支持部材611から上端周縁部230の薬剤搬送経路の上方へ横並び状態で垂れ下がり、通常は前段垂下物612の下端が薬剤の高さより少しだけ高くなるように上下位置が調整される。
The first sorting member 610 (see FIGS. 5(a) and 5(b)) is a support member 611 of a short length that can be adjusted in the vertical position by a manual screw mechanism, and a support member 611 attached to the tip end portion thereof. It is equipped with a preceding stage hanging object 612 which goes up and down with it.
The front-stage hanging object 612 (see FIG. 5B) is a chain in which a plurality of large balls 613 (two spheres in the figure) are loosely connected to each other, and it is easy to use a commercially available ball chain or the like. It can be realized at low cost. In the first sorting member 610, the two front-stage pendants 612 hang down side by side from the support member 611 above the drug delivery path of the upper end peripheral portion 230, and the lower end of the front-stage pendant 612 is usually slightly lower than the height of the drug. The vertical position is adjusted so that it is only higher.

第2仕分け部材620は(図5(a),(c)参照)、これも手動で上下位置を調整しうる長めの支持部材621と、その先端寄り部位に取り付けられて支持部材621に随伴して上下する中段垂下物622及び後段垂下物632と、支持部材621の上下位置調整を担う手動調整機構650とを具備している。
中段垂下物622は(図5(c)参照)、複数の中玉623(図では三個の球体)を緩く連結して鎖状にしたものであるが、中玉623が小粒になり連結個数が増えている。
後段垂下物632も、やはり複数(図では手前七個と奥六個)の小玉633を緩く連結して鎖状にしたものであり、小玉633が更に小粒になり連結個数が増えている。
The second sorting member 620 (see FIGS. 5A and 5C) is also a long supporting member 621 whose vertical position can be manually adjusted, and is attached to a portion near the tip thereof and accompanies the supporting member 621. It includes a middle-stage hanging object 622 and a rear-stage hanging object 632 that move up and down, and a manual adjusting mechanism 650 that adjusts the vertical position of the support member 621.
The middle hanging object 622 (see FIG. 5C) is a plurality of middle balls 623 (three spheres in the figure) that are loosely connected to form a chain. Is increasing.
The post-stage hanging object 632 is also a chain in which a plurality of (seven in the front and six in the back in the figure) small balls 633 are loosely connected to form a chain, and the small balls 633 become smaller and the number of connected pieces increases.

手動調整機構650は、支持部材621を手動操作にて上げてそれと下限設定機構651との間隙を広げてから、下限設定機構651の上に型用薬剤5a(上述した型置場740に置いた型用薬剤5aとは別物であるが同形の薬剤5の一つ)を載置し、それから手動操作にて支持部材621を型用薬剤5aに軽く当たるところまで下げると、支持部材621の上下位置が型用薬剤5aに対応した位置に来るようになっている。
下限設定機構651には、目盛部材652が付設されており(図5(c)参照)、その目盛が下限設定機構651と支持部材621との間隔ひいては型用薬剤5aのサイズを示し更には手動調整機構650によって調整された第2仕分け部材620による規制高さをも示すようになっている。また、支持部材621の上下位置調整に付随して、型用薬剤5aの採寸・表示まで行われるので、第1仕分け部材610の調整の目安にもなる。
The manual adjustment mechanism 650 raises the support member 621 by manual operation to widen the gap between the support member 621 and the lower limit setting mechanism 651, and then, on the lower limit setting mechanism 651, the mold agent 5a (the mold placed in the mold storage 740 described above). When a support member 621 is manually placed on the mold 5a, which is different from the preparation drug 5a but has the same shape, and then the support member 621 is lowered to a position where it lightly hits the mold drug 5a, the vertical position of the support member 621 is changed. It comes to a position corresponding to the mold agent 5a.
A scale member 652 is attached to the lower limit setting mechanism 651 (see FIG. 5(c)), and the scale indicates the distance between the lower limit setting mechanism 651 and the support member 621 and thus the size of the die medicine 5a, and further manual operation. The regulation height by the second sorting member 620 adjusted by the adjustment mechanism 650 is also shown. Further, since the measurement and display of the mold medicine 5a are performed in association with the vertical position adjustment of the support member 621, it also serves as a guide for the adjustment of the first sorting member 610.

さらに、上述した前段垂下物612と中段垂下物622と後段垂下物632とについて、それらの位置関係や役割分担等を説明する。
二つの前段垂下物612は、何れも上端周縁部230の薬剤搬送経路の上方に垂れ下がるが、上端周縁部230の径方向である薬剤搬送経路の横断方向に並んでいる。前段垂下物612の下端位置は、調整方針に依存するので一概には言えないが、大抵は、薬剤搬送経路上で薬剤が重なっていれば上の薬剤に対して干渉するように、薬剤より少し高くされる。大玉613が重めで薬剤の重なりが効率良く解消されるが、自由端である下端の大玉613が直ぐ上の連結部の変形によって逃げるため薬剤への衝撃は少なくて済む。
Further, regarding the above-described front-stage hanging object 612, middle-stage hanging object 622, and rear-stage hanging object 632, their positional relationship, role division, and the like will be described.
Both of the two front-stage hanging objects 612 hang down above the drug transport path of the upper end peripheral portion 230, but are lined up in the transverse direction of the drug transport path that is the radial direction of the upper end peripheral portion 230. The lower end position of the anterior pendant 612 depends on the adjustment policy, and therefore cannot be generally stated. However, in most cases, it is slightly smaller than the drug so that if the drugs overlap on the drug delivery route, they interfere with the above drugs. To be raised. The large balls 613 are heavy and the overlapping of the medicines is efficiently eliminated, but the large balls 613 at the lower end, which is the free end, escape due to the deformation of the connection portion immediately above, so that the impact on the medicine is small.

なお、薬剤が球状の場合は、薬剤が転がり易くて位置が安定しないことが多いが、薬剤が薬剤搬送経路の横断方向で中央など望ましい所に位置しているときには、薬剤が横並びの前段垂下物612の間をすり抜ける。また、薬剤が中央より少し横にずれているときには、位置ずれしている方の前段垂下物612と薬剤とが軽く干渉して、薬剤が中央(転がり易い薬剤では上述した環状回転体200の上端周縁部230の溝231の拡幅部のところ)に寄せられる。これに対し、薬剤が中央から大きく位置ずれしているときには、当たり具合によって中央に寄せられる薬剤もあるが上端周縁部230の上から押し出されて傾斜回転体300の上に戻る薬剤が多い。 When the drug is spherical, the drug is likely to roll and the position is not stable, but when the drug is located at a desired position such as the center in the transverse direction of the drug delivery route, the drug is laid side by side in the front drop. Pass through 612. Further, when the medicine is slightly laterally displaced from the center, the misaligned front-stage hanging object 612 and the medicine are lightly interfered with each other, and the medicine is in the center (the upper end of the annular rotating body 200 described above for a medicine that easily rolls). It is brought close to the widened portion of the groove 231 of the peripheral portion 230. On the other hand, when the drug is largely displaced from the center, some of the drug is pushed to the center depending on the contact condition, but many of the drugs are pushed out from the upper end peripheral portion 230 and return to the top of the inclined rotary body 300.

二つの中段垂下物622は、その支持部材621が規制機構700を跨いでいる跨ぎ仕分け部材になっていて、何れの中段垂下物622も、上端周縁部230の薬剤搬送経路の上方に垂れ下がり、規制機構700(特に第2規制部材720)の横に位置していて横並び垂下物になっている。
また、何れの中段垂下物622も、上端周縁部230の薬剤搬送経路の上方に位置しており、それらが薬剤搬送経路に対しては斜めに並んでいる。
The support members 621 of the two middle-stage hanging objects 622 are straddle sorting members that straddle the regulation mechanism 700, and any middle-stage hanging matter 622 hangs above the drug transport path of the upper end peripheral portion 230 and is regulated. It is located beside the mechanism 700 (particularly the second regulating member 720) and is a side-by-side hanging object.
Further, any of the middle-stage hanging objects 622 is located above the drug delivery path on the upper end peripheral portion 230, and they are arranged obliquely with respect to the drug delivery path.

さらに、支持部材621と手動調整機構650との関係が標準的な設定では中段垂下物622の下端位置を薬剤搬送経路上の薬剤より僅かに低くするようになっている。
そのため、中段垂下物622は、薬剤搬送経路上で薬剤が重なっていれば上の薬剤に対して中玉623が干渉して薬剤の重なりを解消する機能に加え、例えば単独で孤立した状態や斜めがかった横並び状態などでたまたま薬剤搬送経路の内周側に載っているような薬剤を剤搬送経路の中央へ戻すか傾斜回転体300へ戻すか切り分けることで薬剤搬送経路上の薬剤整列機能を強化する機能をも発揮するものとなっている。
Furthermore, in the standard setting of the relationship between the support member 621 and the manual adjustment mechanism 650, the lower end position of the middle-stage hanging object 622 is set to be slightly lower than the medicine on the medicine conveying path.
Therefore, the middle-stage hanging object 622 has a function of eliminating the overlap of the medicines by the middle balls 623 interfering with the medicines above if the medicines overlap each other on the medicine conveyance route, and for example, in the isolated state or at an angle. Strengthening the drug alignment function on the drug delivery route by returning the drug that happens to be on the inner peripheral side of the drug delivery route to the center of the drug delivery route or returning to the inclined rotator 300, depending on whether it is in a side-by-side side-by-side state It also has the function to do.

二つの後段垂下物632は(図5(a)参照)、一方(図では奥の六連物)が上端周縁部230の薬剤搬送経路の内周側の上方に垂れ下がり、他方が(図では手前の七連物)が上端周縁部230の薬剤搬送経路の上方から外れて傾斜回転体300の外周側の上方に垂れ下がり、薬剤搬送経路の横断方向に並んでいる。
しかも、手動調整機構650による支持部材621の高さ調整に伴って、一方の後段垂下物632の下端位置は上述の中段垂下物622の下端位置より少し低くされ、他方の後段垂下物632の下端位置は更に低くされるようになっている。
そのため、上述した大玉613を連ねた第1仕分け部材610と、中玉623を連ねた中段垂下物622と、小玉633を連ねた後段垂下物632は、それらの下端位置が玉の大小の順になっている。
As for the two rear-stage hanging objects 632 (see FIG. 5A ), one (in the figure, the six rearmost objects) hangs above the inner peripheral side of the upper end peripheral portion 230 of the drug transport path, and the other (the front object in the figure). (7 series) deviates from the upper side of the upper end peripheral portion 230 above the drug delivery route and hangs above the outer peripheral side of the inclined rotator 300, and is aligned in the transverse direction of the drug delivery route.
Moreover, with the height adjustment of the support member 621 by the manual adjustment mechanism 650, the lower end position of the one rear stage hanging object 632 is made slightly lower than the lower end position of the above middle stage hanging object 622, and the lower end position of the other rear stage hanging object 632. The position is designed to be lowered further.
Therefore, the lower end positions of the first sorting member 610 in which the large balls 613 are connected, the middle stage pendant 622 in which the middle balls 623 are connected, and the rear stage pendant 632 in which the small balls 633 are connected are in the order of the size of the balls. ing.

さらに(図5(a)参照)、後段垂下物632は、少なくとも内周側のものは(図では手前の七連物)、小玉633の材料に鉄等の磁性体が採用されている。また、これに対応して、第2規制部材720のうち後段垂下物632に近い部位に、永久磁石などからなる引き付け部材640が嵌め込み等にて取り付けられている。そして、その引き付け力が重 力の分力に加勢するため、後段垂下物632は、薬剤搬送経路の上から当接してきた薬剤に対して、穏やかながらも効果的な反力を作用させるものとなっている。これにより、第2規制部材720から離れていた薬剤が第2規制部材720に近づくので、第2規制部材720の機能が強化される。このような後段垂下物632は、自身の薬剤の高さ規制機能よりも第2規制部材720の薬剤の横幅規制の強化を重視したものとなっている。 Further (see FIG. 5( a )), at least the rear-side hanging object 632 on the inner peripheral side (in the figure, the seven consecutive objects) is made of a magnetic material such as iron as the material of the small balls 633. Correspondingly, an attracting member 640 made of a permanent magnet or the like is attached to a portion of the second restricting member 720 near the posterior hanging object 632 by fitting or the like. Then, since the attractive force is added to the component force of gravity, the post-stage hanging object 632 exerts a gentle but effective reaction force on the drug coming in contact from above the drug delivery route. Has become. As a result, the medicine that has been separated from the second restriction member 720 approaches the second restriction member 720, so that the function of the second restriction member 720 is enhanced. Such a post-stage hanging object 632 emphasizes the strengthening of the lateral width restriction of the medicine of the second restriction member 720 rather than the height restriction function of the medicine itself.

図6に示した容器延伸体800は、新たに追加されたものである。図6は、薬剤フィーダ100の容器延伸体800の構造を示しており、(a)が斜視図、(b)が底面図、(c)が側面図である。 The stretched container 800 shown in FIG. 6 is newly added. 6A and 6B show the structure of the container stretched body 800 of the drug feeder 100. FIG. 6A is a perspective view, FIG. 6B is a bottom view, and FIG. 6C is a side view.

容器延伸体800は(図6参照)、環状回転体200の上端周縁部230の中空と同程度か少し小さな貫通穴811が形成されている板部810と、貫通穴811の周縁部を下端として上方へ立ち上がっている筒部820と、貫通穴811の周縁部の一部を上端として下方へ突き出た垂下部830とを具備したものである。
板部810は、周壁11に対して、直に、或いは排出ガイド13の形成された板体を介して間接的に、上乗せ状態で着脱しうるものであり、装着状態では貫通穴811が環状回転体200や傾斜回転体300の上方に位置するとともに、筒部820が板部810から上方へ少し広がりながら突き出て、貫通穴811を上方へ伸ばすことで、薬剤の収容量を増加させるようになっている。
The container extending body 800 (see FIG. 6) includes a plate portion 810 having a through hole 811 formed therein which is as small as or slightly smaller than the hollow of the upper end peripheral portion 230 of the annular rotating body 200, and the peripheral portion of the through hole 811 as the lower end. It is provided with a cylindrical portion 820 that rises upward and a hanging portion 830 that protrudes downward with a part of the peripheral edge portion of the through hole 811 as the upper end.
The plate portion 810 can be attached/detached to/from the peripheral wall 11 directly or indirectly via the plate body on which the discharge guide 13 is formed. In the mounted state, the through hole 811 rotates in an annular shape. While being located above the body 200 and the tilted rotary body 300, the tubular portion 820 projects from the plate portion 810 while slightly expanding upward, and the through hole 811 is extended upward, thereby increasing the amount of medicine to be contained. ing.

また、板部810を周壁11に対して装着した状態では、垂下部830が、環状回転体200の内側(少なくとも上端周縁部230の中空の内側)に入り込んでいて、規制機構700(特に第1規制部材710や第2規制部材720)の横で近くに位置することで、筒部820の中の薬剤が規制機構700やその辺りの上端周縁部230の所へ雪崩れ込むのが防止されるとともに、排出ガイド13よりも手前で上端周縁部230の上から外された薬剤が傾斜回転体300の上へ円滑に戻ることができるようになっている。
さらに、貫通穴811の一部に膨らみ812が形成されるとともに(図6(b)参照)、そこに連なる筒部820の該当部分にも膨らみ821が形成されていて(図6(a)参照)、傾斜回転体300の上昇部との不所望な干渉を回避するとともに、傾斜回転体300から環状回転体200へ薬剤を引き渡すことが円滑に行えるようにもなっている。
Further, in the state where the plate portion 810 is attached to the peripheral wall 11, the hanging portion 830 has entered the inside of the annular rotating body 200 (at least the inside of the hollow of the upper end peripheral portion 230), and the regulating mechanism 700 (particularly the first portion). By being located next to and adjacent to the restriction member 710 and the second restriction member 720, it is possible to prevent the medicine in the cylindrical portion 820 from avalanching into the restriction mechanism 700 and the upper end peripheral portion 230 around the restriction mechanism 700. At the same time, the medicine removed from the upper end peripheral portion 230 before the discharge guide 13 can smoothly return to the upper portion of the inclined rotating body 300.
Further, a bulge 812 is formed in a part of the through hole 811 (see FIG. 6(b)), and a bulge 821 is also formed in a corresponding portion of the tubular portion 820 connected to the bulge 812 (see FIG. 6(a)). ), while avoiding undesired interference with the rising portion of the inclined rotary body 300, the medicine can be smoothly transferred from the inclined rotary body 300 to the annular rotary body 200.

図7に示した大蓋110も、新たに追加されたものである。図7は、容器延伸体800を装備したものと装備していないものとを並べた二つの薬剤フィーダ100,100に係る全体構造を示しており、同図(a)は、大蓋110を開けた状態の薬剤フィーダ100に係る外観斜視図、同図(b)は、大蓋110を閉じた状態の薬剤フィーダ100に係る外観斜視図である。 The large lid 110 shown in FIG. 7 is also newly added. FIG. 7 shows an overall structure of two drug feeders 100, 100 in which a container extending body 800 is provided and a container extending body is not provided, and FIG. FIG. 3B is an external perspective view of the medicine feeder 100 in the closed state, and FIG. 3B is an external perspective view of the medicine feeder 100 in the state where the large lid 110 is closed.

大蓋110は、周壁11又は排出ガイド13の形成板体等の上面に対して蝶番部材を介して連結されていて周壁11の上方を開閉しうるようになっている。なお、蝶番部材には双安定なバネ等が組み込まれていて、大蓋110は全開状態か全閉状態の何れかで安定するようになっている。
また、大蓋110は、それを閉めても傾斜回転体300等の動作状況を目視で確認できるように、透明か半透明の部材からなる。
The large lid 110 is connected to the upper surface of the peripheral wall 11 or the plate body of the discharge guide 13 or the like via a hinge member so that the upper portion of the peripheral wall 11 can be opened and closed. A bistable spring or the like is incorporated in the hinge member so that the large lid 110 is stable in either the fully open state or the fully closed state.
Further, the large lid 110 is made of a transparent or semi-transparent member so that the operating state of the tilted rotating body 300 and the like can be visually confirmed even when the large lid 110 is closed.

さらに、大蓋110と容器延伸体800とを装着した薬剤フィーダ100では、大蓋110を閉めたときに、大蓋110の下面が容器延伸体800の筒部820の上端に対して接触間際まで接近するように、大蓋110の深さと容器延伸体800の高さとが関連付けて設計されているので、大蓋110を閉めると容器延伸体800の筒部820の上端開口が大蓋110の下面によって薬剤通過不能な状態まで閉じられるようになっている。
なお、図示のように蝶番部材を薬剤フィーダ100の後方(図では右後)に設けて大蓋110を前方へ下ろすと薬剤フィーダ100が閉まり大蓋110を後方へ上げる薬剤フィーダ100が開くようにしておくと複数の薬剤フィーダ100を横に並べても使い易いが、大蓋110が他の方向へ開くようにしても良い。
Further, in the medicine feeder 100 equipped with the large lid 110 and the container extending body 800, when the large lid 110 is closed, the lower surface of the large lid 110 comes into contact with the upper end of the tubular portion 820 of the container extending body 800 until just before the contact. Since the depth of the large lid 110 and the height of the container extending body 800 are designed so as to be close to each other, when the large lid 110 is closed, the upper end opening of the cylindrical portion 820 of the container extending body 800 causes the lower surface of the large lid 110 to open. It is designed so that it can be closed to prevent drug passage.
As shown in the figure, a hinge member is provided at the rear of the drug feeder 100 (right rear in the figure) and when the large lid 110 is lowered to the front, the drug feeder 100 closes and the large lid 110 is raised backward so that the drug feeder 100 opens. Although it is easy to use a plurality of drug feeders 100 arranged side by side, the large lid 110 may be opened in another direction.

図8(a)に示した回転駆動機構500は、既述の回転駆動機構50を改造したものであり、同図は、回転駆動機構500を内蔵した薬剤フィーダ100の内部構造を示している。また、図8(b)に示したコントローラ570等(制御部)は、既述の回転駆動制御機能を拡張したものであり、同図は、その回転駆動制御に係るブロック構成図である。 The rotary drive mechanism 500 shown in FIG. 8A is a modification of the rotary drive mechanism 50 described above, and this figure shows the internal structure of the drug feeder 100 incorporating the rotary drive mechanism 500. Further, the controller 570 and the like (control unit) shown in FIG. 8B are obtained by expanding the rotation drive control function described above, and FIG. 8 is a block configuration diagram relating to the rotation drive control.

回転駆動機構500は(図8(a)参照)、回転駆動部材51に代わる回転駆動部材511及び回転駆動部材512と、回転駆動モータ54に代わる回転駆動モータ541及び回転駆動モータ542と、新たに追加された傾斜回転体装着検出手段550と、符号を付して明示した薬剤落下検出手段560とを具備している。回転駆動モータ541は回転駆動部材511を介して環状回転体200を回転させるものであり、回転駆動モータ542は回転駆動部材512を介して傾斜回転体300を回転させるものであり、そのように駆動系が二系統に分かれたことで、環状回転体200と傾斜回転体300とが独立駆動しうるものとなっている。また、回転駆動モータ541にも、回転駆動モータ542にも、コントローラ570の制御に応じて回転の向きを正転か逆転か択一的に切り替えることが可能なものが採用されている。そのため、回転駆動機構500は環状回転体200及び傾斜回転体300の回転方向を個別に反転しうるものとなっている。 The rotary drive mechanism 500 (see FIG. 8A) includes a rotary drive member 511 and a rotary drive member 512 which replace the rotary drive member 51, a rotary drive motor 541 and a rotary drive motor 542 which replace the rotary drive motor 54, and The tilted rotary body attachment detecting means 550 and the medicine drop detecting means 560 added with reference numerals are added. The rotary drive motor 541 rotates the annular rotary body 200 via the rotary drive member 511, and the rotary drive motor 542 rotates the inclined rotary body 300 via the rotary drive member 512. Since the system is divided into two systems, the annular rotating body 200 and the inclined rotating body 300 can be independently driven. Further, both the rotary drive motor 541 and the rotary drive motor 542 are capable of selectively switching the rotation direction between forward rotation and reverse rotation under the control of the controller 570. Therefore, the rotary drive mechanism 500 can individually reverse the rotation directions of the annular rotary body 200 and the tilt rotary body 300.

傾斜回転体装着検出手段550は、傾斜回転体300の回転軸部370の軸支部などに付設されたフォトセンサ等からなり、傾斜回転体300が適切に装着されるとセンサ検出先に回転軸部370が位置するのに対し、傾斜回転体300が取り外されたり装着されても装着状態が不適切だったりすると回転軸部370がセンサ検出先から外れるような部位や姿勢で設けられていて、傾斜回転体300の着脱を検出するものとなっている。
薬剤落下検出手段560は、落下排出口14から下方へ延びた薬剤の落下経路に臨むフォトセンサ等からなり、環状回転体200の上端周縁部230に整列してから順に落下経路を通って逐次排出された薬剤の落下状態を検出するようになっている。
The tilted rotary body mounting detection means 550 is composed of a photosensor or the like attached to the shaft support portion of the rotary shaft portion 370 of the tilted rotary body 300, etc., and when the tilted rotary body 300 is properly mounted, the rotary shaft portion is detected as a sensor. In contrast to the position of the 370, the inclined shaft 300 is provided in such a position and posture that the rotating shaft 370 will be disengaged from the sensor detection destination if the mounted state is inappropriate even if it is removed or mounted. The attachment/detachment of the rotating body 300 is detected.
The drug drop detecting means 560 is composed of a photo sensor or the like that extends downward from the drop discharge port 14 and faces the drop path of the drug, and is sequentially discharged through the drop path after being aligned with the upper end peripheral portion 230 of the annular rotary body 200. It is designed to detect the dropped state of the drug.

コントローラ570は(図8(b)参照)、マイクロプロセッサを主体とした制御回路(制御手段)であり、図示しない操作部や上位装置から初期化指示や薬剤排出指示といった各種の指示を受けて独立駆動可能な一組の回転駆動モータ541,542の回転制御を行うようになっている。そして、そのために、初期化指示の有無や薬剤落下検出手段560の検出結果を参照して回転駆動モータ541の回転方向および回転速度と回転駆動モータ541,542の回転方向および回転速度とを調整しながら薬剤を逐次排出させる薬剤排出動作制御プログラム(薬剤排出動作制御手段)と、薬剤排出指示で指示された個数だけ薬剤を排出させるための剤数管理プログラム(剤数管理手段)とを具備している。 The controller 570 (see FIG. 8B) is a control circuit (control means) mainly including a microprocessor, and is independent by receiving various instructions such as an initialization instruction and a drug discharge instruction from an operation unit (not shown) or a host device. The rotation control of a pair of drivable rotary drive motors 541 and 542 is performed. For that purpose, the rotation direction and rotation speed of the rotation drive motor 541 and the rotation direction and rotation speed of the rotation drive motors 541 and 542 are adjusted with reference to the presence or absence of the initialization instruction and the detection result of the medicine drop detection means 560. While being provided with a drug discharge operation control program (drug discharge operation control means) for sequentially discharging the drug and a drug number management program (drug number management means) for discharging the drug in the number instructed by the drug discharge instruction There is.

剤数管理プログラムによる制御では、薬剤フィーダ100の脱着や電源投入の直後さらには薬剤フィーダ100への薬剤補充やリセット操作さらには薬剤排出タイムアウトの後などに出される初期化指示を受けると薬剤サイズの推定値をクリアするようになっている。また、傾斜回転体装着検出手段550の検出結果を監視することで傾斜回転体300ひいては環状回転体200も適切に装備されているか否かを判別し、その装備が適切なときだけ次の剤数管理処理を行うようにもなっている。すなわち、この剤数管理処理では、薬剤排出動作制御プログラムを起動し、それから、薬剤落下検出手段560の検出結果を監視して排出薬剤の個数を把握し、薬剤排出指示で指定された個数だけ薬剤排出が行われたら薬剤排出動作制御プログラムの動作を停止させる、といったことが行われる。 In the control by the drug number management program, the drug size is changed when receiving the initialization instruction issued immediately after the drug feeder 100 is attached or detached or the power is turned on, the drug feeder 100 is refilled or reset, and after the drug discharge time-out. It is designed to clear the estimated value. Further, by monitoring the detection result of the tilted rotary body attachment detection means 550, it is determined whether or not the tilted rotary body 300 and thus the annular rotary body 200 are also properly equipped, and only when the equipment is appropriate, the next agent number It also manages. That is, in this drug number management processing, the drug ejection operation control program is started, and then the detection result of the drug drop detection means 560 is monitored to grasp the number of ejected drugs, and the number of drugs specified by the drug ejection instruction is grasped. When the drug is discharged, the operation of the drug discharge operation control program is stopped.

薬剤排出動作制御プログラムによる制御では、上述した薬剤サイズの推定値を確認して推定値がクリアされているときには、薬剤サイズの推定値を得る前の初期動作を行うようになっている。この初期動作時には、環状回転体200と傾斜回転体300とを合わせた回転容器200+300に係る回転速度を先ず高速から始めて次に低速に切り替えるようになっている。先行の高速回転は、初期状態の薬剤フィーダ100において最初の薬剤が傾斜回転体300から環状回転体200へ乗り移るまでの想定時間だけ、例えば傾斜回転体300が4分の1回転する程度の時間だけ、行われる。次の低速回転は、転がり易い薬剤でも勢いで余分に落下排出口14へ行ってしまうことが無いような低速で、薬剤落下検出手段560にて最初の落下薬剤が検出されるまで、行われる。こうすることにより、薬剤のサイズが不明な段階でも過剰排出を回避しつつ所用時間を短縮することができる。 In the control by the drug discharge operation control program, when the above-mentioned estimated value of the medicine size is confirmed and the estimated value is cleared, the initial operation before obtaining the estimated value of the medicine size is performed. At the time of this initial operation, the rotation speed of the rotary container 200+300 in which the annular rotary body 200 and the inclined rotary body 300 are combined is switched from a high speed to a low speed. The preceding high-speed rotation is for an estimated time until the first drug is transferred from the tilting rotary body 300 to the annular rotary body 200 in the drug feeder 100 in the initial state, for example, only for about a quarter rotation of the tilting rotary body 300. , Done. The next low-speed rotation is performed at such a low speed that even the easily-rolling medicine does not excessively go to the drop discharge port 14 until the medicine falling detection means 560 detects the first falling medicine. By doing so, it is possible to shorten the required time while avoiding excessive discharge even at the stage where the size of the drug is unknown.

また、薬剤排出動作制御プログラムによる制御では、薬剤落下検出手段560にて薬剤の落下が検出されると、その度に剤数管理プログラムに薬剤一個排出済みの通知を行うが、薬剤サイズの推定値がクリアされている初期動作時には、その推定値のセットも行うようになっている。具体的には、最初の落下薬剤の検出時に薬剤検出時間長を計測して、その計測値をそのまま或いは計測値に所定の定数を乗じた値を薬剤サイズの推定値に採用する、といったことが行われる。これで、初期動作は完了する。 Further, in the control by the drug discharge operation control program, when the drug drop detecting means 560 detects the drop of the drug, the drug number management program is notified each time the drug is discharged, but the estimated value of the drug size. At the initial operation when is cleared, the estimated value is also set. Specifically, the drug detection time length is measured when the first dropped drug is detected, and the measured value is used as it is or a value obtained by multiplying the measured value by a predetermined constant is used as the estimated value of the drug size. Done. This completes the initial operation.

推定値がセットされた後や推定値が既にセットされていたときには、薬剤排出動作制御プログラムによる制御では、定常動作を行うようになっている。この定常動作では、薬剤サイズの推定値に対応して回転容器200+300の回転速度を可変制御する。具体的には、例えば上記の推定値の逆数をそのまま或いはそれに定数を乗じた値を回転容器200+300の制御目標値にしてフィードバック制御を行うようになっている。また、剤数管理プログラムから動作停止を指示されたとき、薬剤排出動作制御プログラムの制御では、薬剤の過剰な転動の防止のため回転容器200+300の回転を急停止するのでなく徐々に減速したり、薬剤の過剰な落下の防止のため逆回転を行わせるようにもなっている。 After the estimated value is set or when the estimated value has already been set, the drug discharge operation control program performs a steady operation. In this steady operation, the rotation speed of the rotary container 200+300 is variably controlled according to the estimated value of the medicine size. Specifically, for example, the reciprocal of the estimated value is used as it is or a value obtained by multiplying it by a constant is used as a control target value of the rotary container 200+300 to perform feedback control. Further, when the operation stop is instructed from the agent number management program, the rotation of the rotary container 200+300 is not gradually stopped but is gradually decelerated under the control of the medicine discharge operation control program in order to prevent excessive rolling of the medicine. In order to prevent the drug from falling excessively, the reverse rotation is also performed.

回転容器200+300の逆回転は、薬剤排出指示で指示された個数だけ薬剤を排出し終えたときに行われるようになっている。
そのため、例えば薬剤排出指示が上位装置の薬剤分包機から出されたような場合、謂わば一包単位での逆転式排出動作が行われるようになっている。
また、回転容器200+300の逆回転は、環状回転体200と傾斜回転体300とを共に逆回転させるのも可能であるが、この実施例では、環状回転体200には正転を継続させ、傾斜回転体300だけ少し逆回転させるようになっている。
The reverse rotation of the rotary container 200+300 is performed when the number of medicines indicated by the medicine discharge instruction is completely discharged.
Therefore, for example, when a medicine discharging instruction is issued from the medicine packing machine of the higher-level device, a so-called reversal discharging operation is performed in so-called one-pack unit.
Further, in the reverse rotation of the rotary container 200+300, it is possible to rotate both the annular rotary body 200 and the inclined rotary body 300 in the reverse direction, but in this embodiment, the annular rotary body 200 is continuously rotated in the forward direction and is inclined. Only the rotating body 300 is adapted to be slightly rotated in the reverse direction.

このような実施例1の薬剤フィーダ100について、その使用態様及び動作を、図面を引用して説明する。薬剤フィーダ10について既述した事項を踏襲した内容については簡潔に述べるにとどめ、以下、改良点や新たな事項を中心に詳述する。 The usage mode and operation of the medicine feeder 100 according to the first embodiment will be described with reference to the drawings. The contents of the drug feeder 10 that follow the items already described will be described only briefly, and hereinafter, improvements and new items will be mainly described.

先ず、回転容器200が適切に装着されたうで傾斜回転体300も適切に装着されていないと、傾斜回転体装着検出手段550が傾斜回転体300の回転軸部370を検出できず、それに応じたアラーム等が発せられるので、それに気づいたら回転容器200+300の装着を遣り直しておく。
そして、薬剤フィーダ100を使用して多数の薬剤5を逐次送出するには、大蓋110を開け(図7(a)参照)、薬剤5の量が回転容器200+300の容量を超えない場合は容器延伸体800を装着するまでも無いが(図7(a)の右前の薬剤フィーダ100を照)、薬剤5の量が回転容器200+300の容量を超える場合は容器延伸体800を装着してから(図7(a)の左奥の薬剤フィーダ100を参照)、所要個数かそれより多めの薬剤5を回転容器200+300の中へランダム投入する(なお、薬剤5の図示は、既述した図12や図13に準ずるので、ここでは割愛した)。
First, if the rotary container 200 is properly mounted and the tilting rotor 300 is not also properly mounted, the tilting rotor mounting detector 550 cannot detect the rotation shaft portion 370 of the tilting rotor 300, and accordingly Since an alarm etc. will be issued, if you notice it, reattach the rotating container 200+300 again.
Then, in order to sequentially deliver a large number of medicines 5 using the medicine feeder 100, the large lid 110 is opened (see FIG. 7A), and when the quantity of the medicines 5 does not exceed the capacity of the rotary container 200+300, the containers are Although it is not necessary to attach the stretched body 800 (see the medicine feeder 100 in the front right of FIG. 7A), when the amount of the medicine 5 exceeds the capacity of the rotary container 200+300, after the container stretched body 800 is mounted ( 7(a) (see the medicine feeder 100 on the left back), the required number of medicines 5 or more are randomly charged into the rotary container 200+300 (the medicine 5 is illustrated in FIG. 12 and FIG. Since it conforms to Fig. 13, it is omitted here).

また、薬剤の投入の前でも後でも良いので、規制機構700による薬剤搬送経路上の幅規制に係る調整作業と(図4参照)、仕分け機構600による薬剤搬送経路上の高さ規制に係る調整作業を行う(図5参照)。なお、容器延伸体800を装着しても規制機構700の型置場740や仕分け機構600の手動調整機構650等は隠れないので(図7参照)、容器延伸体800を装着しても装着しないときと同様に調整することができる。
規制機構700の幅規制の調整は(図4(a),(b)参照)、型用薬剤5aを型置場740に置いてから小蓋741を閉め更に止めネジ742を締めることで、型用薬剤5aが確実に固定されるうえ、型用薬剤5aのセット状態を目視で簡便に確認することができ、更に、バネ730の付勢によって二連の規制部材710,720の位置合わせも容易かつ的確になされる。
Further, since it may be before or after the introduction of the medicine, the adjustment work related to the width regulation on the medicine conveyance path by the regulation mechanism 700 (see FIG. 4) and the adjustment work regarding the height regulation on the medicine conveyance path by the sorting mechanism 600. Work (see Figure 5). Even when the stretched container 800 is attached, the mold storage 740 of the regulation mechanism 700, the manual adjustment mechanism 650 of the sorting mechanism 600, and the like are not hidden (see FIG. 7). Can be adjusted as well.
Adjustment of the width regulation of the regulation mechanism 700 (see FIGS. 4A and 4B) is performed by placing the mold agent 5a in the mold storage 740, closing the small lid 741 and further tightening the set screw 742. The medicine 5a is securely fixed, and the set state of the mold medicine 5a can be easily and visually confirmed. Furthermore, the biasing of the spring 730 facilitates the alignment of the two restricting members 710 and 720. Be done exactly.

仕分け機構600のうち第2仕分け部材620による高さ規制の調整は(図5(a),(c)参照)、もう一つの型用薬剤5aを下限設定機構651の上に置いてから手動調整機構650を下げて型用薬剤5aを挟むことで容易かつ的確に遂行することができる。ほとんどの場合それだけで足りるが、試運転や以前の実運転などに基づいて微調整を加えたいときには、必要なら型用薬剤5aを取り外して、目盛を参照して支持部材621を少しだけ上げ下げする。
また(図5(a),(b)参照)、仕分け機構600のうち第1仕分け部材610による高さ規制の調整は、型用薬剤5aのサイズを示している目盛部材652を参照しながら手動調整を行うことで、これも容易かつ的確に済ませることができる。
In the adjustment of the height regulation by the second sorting member 620 of the sorting mechanism 600 (see FIGS. 5A and 5C ), another drug for mold 5 a is placed on the lower limit setting mechanism 651 and then manually adjusted. By lowering the mechanism 650 and sandwiching the molding agent 5a, it is possible to carry out easily and accurately. In most cases, this is sufficient, but when fine adjustment is desired based on a trial run or previous actual run, the mold agent 5a is removed if necessary, and the support member 621 is slightly raised or lowered with reference to the scale.
Further (see FIGS. 5A and 5B), adjustment of the height regulation by the first sorting member 610 of the sorting mechanism 600 is performed manually with reference to the scale member 652 indicating the size of the die medicine 5a. This can be done easily and accurately by making adjustments.

それらの準備作業が総て済んだら、大蓋110を閉めて(図7(b)参照)、薬剤の逐次排出に備える。大蓋110を閉めると、周壁11や回転容器200+300の上方が閉じられるとともに、容器延伸体800の筒部820の上端開口も実質的に密閉されて薬剤5のこぼれ落ちが防止される。また、大蓋110の開閉操作や手動操作に応じて初期化指示が出され(図8(b)参照)、それに応じてコントローラ570では薬剤サイズの推定値がクリアされて、薬剤排出の準備が進む。もっとも、薬剤フィーダ100が排出動作を行うに際しては、傾斜回転体装着検出手段550が傾斜回転体300の回転軸部370を検出しているという条件が課されているので、薬剤の逐次排出は、回転容器200+300が適切に装着されている安全な状態でのみ(図8(a)参照)、実行される。 When all the preparatory work is completed, the large lid 110 is closed (see FIG. 7B) to prepare for the sequential discharge of the drug. When the large lid 110 is closed, the peripheral wall 11 and the upper part of the rotary container 200+300 are closed, and the upper end opening of the tubular portion 820 of the container extending body 800 is also substantially sealed to prevent the drug 5 from spilling. Further, an initialization instruction is issued according to the opening/closing operation or the manual operation of the large lid 110 (see FIG. 8B), and the controller 570 clears the estimated value of the medicine size in response to the preparation for medicine ejection. move on. However, when the medicine feeder 100 performs the discharging operation, the condition that the tilting rotor mounting detection means 550 detects the rotation shaft portion 370 of the tilting rotor 300 is imposed, and therefore the successive discharging of the medicines is performed. It is executed only in a safe state where the rotating container 200+300 is properly mounted (see FIG. 8A).

そして、薬剤フィーダ100において薬剤の逐次排出の準備が整ったところで、コントローラ570に薬剤排出指示が届くと、剤数管理プログラムの剤数管理下で薬剤排出動作制御プログラムの薬剤排出動作制御が行われる。
当初は薬剤サイズの推定値がクリアされているので、初期動作が行われ、回転容器200+300の回転が先ず高速から始まる。もっとも、高速とは言っても、脆い薬剤5が表面等に崩れや欠けといった損傷を負うほど高速ではない。
そして、最初の薬剤が傾斜回転体300から環状回転体200へ乗り移る頃には、回転容器200+300の回転が低速になる。そのため、最初の薬剤5が割と早めに環状回転体200の上に送り込まれるが、転がり易い薬剤でも勢い余って落下排出口14へ行ってしまうといった不所望な事態には至らない。
Then, when a drug discharge instruction arrives at the controller 570 when the drug feeder 100 is ready for sequential drug discharge, the drug discharge operation control of the drug discharge operation control program is performed under the drug number management of the drug number management program. ..
Initially, since the estimated value of the medicine size is cleared, the initial operation is performed, and the rotation of the rotary container 200+300 starts at a high speed. However, even though the speed is high, the speed is not so high that the brittle chemical 5 suffers damage such as breakage or chipping on the surface or the like.
Then, when the first medicine is transferred from the inclined rotary body 300 to the annular rotary body 200, the rotation of the rotary container 200+300 becomes slow. Therefore, the first medicine 5 is fed onto the annular rotary body 200 relatively early, but an undesired situation in which the medicine that easily rolls is too much force to go to the drop discharge port 14 does not occur.

低速回転時には薬剤5が傾斜回転体300の周縁部分の勢いに連れて環状回転体200の傾斜内面を駆け上がることは期待できないが、傾斜回転体300の周縁部には外下り傾斜の引渡部340が形成されているので(図1参照)、それが傾斜回転体300の回転に伴って下降したときには傾斜回転体300の上面央部320の上などから薬剤5が落ち込む。そして、引渡部340が傾斜回転体300の更なる回転に伴って上昇するに連れ、引渡部340の薬剤5が後方の押上部350により押し上げられる。
それだけでも薬剤5が傾斜回転体300によって環状回転体200の上へ運ばれるが、凸部360の付設された引渡部340では、凸部360の基部361が加わって押上部350の高さが増しているうえ、引渡部340の内周側も凸部360の延伸部362によって高められているので、例え傾斜回転体300の回転が極めて遅くても、高い確率で薬剤5が傾斜回転体300から環状回転体200へ押し上げ移載される。
While the medicine 5 cannot be expected to run up the inclined inner surface of the ring-shaped rotating body 200 along with the momentum of the peripheral portion of the inclined rotating body 300 at the time of low-speed rotation, the transfer portion 340 having an outer downward slope is provided at the peripheral portion of the inclined rotating body 300. Since it is formed (see FIG. 1), when it descends with the rotation of the tilting rotary body 300, the drug 5 falls from above the central portion 320 of the upper surface of the tilting rotary body 300. Then, as the delivery section 340 rises with further rotation of the tilting rotor 300, the medicine 5 in the delivery section 340 is pushed up by the rear pusher 350.
The medicine 5 is carried by the inclined rotary body 300 onto the annular rotary body 200 by itself, but in the transfer portion 340 provided with the convex portion 360, the base 361 of the convex portion 360 is added to increase the height of the push-up portion 350. In addition, since the inner peripheral side of the transfer portion 340 is also raised by the extending portion 362 of the convex portion 360, even if the rotation of the tilted rotary body 300 is extremely slow, the medicine 5 is highly likely to be removed from the tilted rotary body 300. It is pushed up and transferred to the annular rotating body 200.

また、傾斜回転体300の上面のうち比較的平坦な上面央部320には並行波状凹凸321が形成されているので、上面央部320の上に乗っている薬剤5は、傾斜回転体300が軸回転すると、重力の相対的な作用方向が変化する状態の下で並行波状凹凸321の摩擦力の作用方向も変化するため、傾斜回転体300の軸回転がゆっくりでも効果的に撹拌さるので、次々に上面央部320から引渡部340へ滑り込む。さらに、その引渡部340にも、並行波状凹凸321と同様の並行波状凹凸が形成されているので、引渡部340の薬剤5は、押上部350によって押し上げられる際にも、塊になっていれば多くが速やかに崩れるので、薬剤5が傾斜回転体300から環状回転体200の上端周縁部230へ乗り移るときには、複数個が上下に重なった状態の薬剤5,5がかなり減っている。 Further, since the parallel wave-shaped irregularities 321 are formed on the relatively flat upper surface central portion 320 of the upper surface of the inclined rotating body 300, the medicine 5 on the upper surface central portion 320 is When the shaft rotates, the action direction of the frictional force of the parallel wavy irregularities 321 also changes under the condition that the relative action direction of gravity changes. Therefore, the axial rotation of the inclined rotary body 300 is effectively stirred even if the axial rotation is slow. The upper surface central part 320 slides into the transfer part 340 one after another. Further, since parallel wave-shaped irregularities similar to the parallel wave-shaped irregularities 321 are formed also in the delivery section 340, if the medicine 5 of the delivery section 340 is lumped even when pushed up by the pusher 350. Most of them collapse quickly, so that when the medicine 5 is transferred from the inclined rotary body 300 to the upper end peripheral portion 230 of the annular rotary body 200, the quantities of the chemicals 5 and 5 in a state in which a plurality of the medicines 5 are vertically overlapped are considerably reduced.

そして、環状回転体200の上端周縁部230の上に乗った薬剤5は(図2(a)参照)、転がり易いものの場合は転がって溝231に至ると溝幅の広い所で安定し(図2(b),図3参照)、転がり難いものでも溝231の所では軽い干渉により安定し、薬剤搬送経路をなす上端周縁部230の巡回運動によって、順に(図5(a)参照)、仕分け機構600の第1仕分け部材610の前段垂下物612の下と、規制機構700の第1規制部材710の内周側と、規制機構700の第2規制部材720と仕分け機構600の第2仕分け部材620の中段垂下物622との間と、規制機構700の第2規制部材720と仕分け機構600の第2仕分け部材620の後段垂下物632との間と、排出ガイド13の外周側と、落下排出口14へ搬送される。なお、その搬送中には、上端周縁部230が落下排出口14の位置を高める向きに角度βだけ傾斜していることから(図2(c)参照) 、重力の分力が薬剤5を押し戻そうとするが、その分力は微小であって溝231の干渉などによる推進力には全く及ばないので、転がり易い薬剤5も不都合なく搬送される。 Then, the medicine 5 on the upper end peripheral portion 230 of the annular rotating body 200 (see FIG. 2A) is stable in a wide groove when it rolls and reaches the groove 231 when it is easy to roll (see FIG. 2(b) and FIG. 3), even if it is hard to roll, it stabilizes at the groove 231 due to light interference, and is sorted in order (see FIG. 5(a)) by the circular movement of the upper end peripheral portion 230 that forms the drug delivery path. Below the front drop 612 of the first sorting member 610 of the mechanism 600, on the inner peripheral side of the first regulating member 710 of the regulating mechanism 700, the second regulating member 720 of the regulating mechanism 700, and the second sorting member of the sorting mechanism 600. 620 to the middle stage hanging object 622, between the second regulating member 720 of the regulating mechanism 700 and the rear stage hanging matter 632 of the second sorting member 620 of the sorting mechanism 600, the outer peripheral side of the discharge guide 13, and the drop discharge. It is conveyed to the exit 14. During the transportation, since the upper end peripheral portion 230 is inclined by the angle β in the direction to raise the position of the drop discharge port 14 (see FIG. 2C), the component force of gravity pushes the medicine 5. Although it tries to return, since the component force thereof is minute and does not reach the propulsive force due to the interference of the groove 231 at all, the easily rollable medicine 5 is also conveyed without inconvenience.

その搬送状況について段階を追って詳述する。先ず、薬剤5が仕分け機構600の前段垂下物612の下に来ると(図5(a),(b)参照)、上端周縁部230の薬剤搬送経路の概ね中央に位置している単独の薬剤5は、平たいものであれ球状のものであれ、前段垂下物612と干渉することなく円滑に搬送されるが、他の薬剤5に乗り上げているものや寄り掛かっているものは、前段垂下物612の下部と干渉するので、乗り上げ等が解消されることが多い。しかも、干渉した薬剤5は二連の前段垂下物612の間すなわち薬剤搬送経路の中央に寄せられか、薬剤搬送経路より内周側へ押されて傾斜回転体300の上へ戻されるか、何れかに振り分けられることが多い。また、そのときの干渉は、前段垂下物612が変形して逃げやすいものなので、薬剤5が脆いものであっても壊れ難い。
このように、前段垂下物612の所では、薬剤5の高さ規制が緩やかに行われるとともに、横幅方向への振り分けも、状況によっては、それなりに行われる。
The transport status will be described in detail step by step. First, when the medicine 5 comes under the front-stage hanging object 612 of the sorting mechanism 600 (see FIGS. 5A and 5B ), the single medicine located at the approximate center of the medicine conveying path of the upper end peripheral portion 230. No. 5 is flat or spherical, and is smoothly conveyed without interfering with the front drop 612. However, if the other drug 5 is leaning on or leaning against the front drop 612, Since it interferes with the lower part of the vehicle, riding etc. is often eliminated. Moreover, the interfering drug 5 is moved between the two preceding pendants 612, that is, in the center of the drug delivery route, or is pushed toward the inner peripheral side of the drug delivery route and returned to the top of the inclined rotating body 300. Often distributed to crabs. Further, the interference at that time is such that the front-stage hanging object 612 is deformed and easily escapes, so that even if the medicine 5 is fragile, it is difficult to break.
In this way, at the position of the front drop 612, the height of the medicine 5 is gently regulated, and the distribution in the lateral width direction is also performed depending on the situation.

次に、薬剤5が規制機構700の第1規制部材710の横に来ると(図5(a)参照)、第1規制部材710の内周側面部には横幅規制機能を担う下段部分711が形成されているので(図4(c)参照)、それによって、横並びの薬剤5,5については、内周側のものが薬剤搬送経路上から傾斜回転体300の方へ押し出されるか、薬剤搬送経路上で前後に並び直されることになる。また、第1規制部材710の内周側面部には高さ規制機能を担う上段部分712も形成されているので(図4(c)参照)、他の薬剤5に乗り上げているものや寄り掛かっているものは、上段部分712の張り出しやその下の傾斜面と干渉するので、薬剤5同士の乗り上げ等が解消される。乗り上げ等は、既に第1仕分け部材610によって或る程度まで解消済みなので、更なる解消により、ほぼ解消される。 Next, when the medicine 5 comes to the side of the first restricting member 710 of the restricting mechanism 700 (see FIG. 5A), the inner peripheral side surface portion of the first restricting member 710 is provided with the lower portion 711 having the lateral width restricting function. Since it is formed (see FIG. 4( c )), the medicines 5 and 5 arranged side by side are pushed out toward the inclined rotator 300 from the medicine conveying path or the medicine is conveyed. It will be rearranged back and forth on the route. Further, since an upper step portion 712 having a height regulating function is also formed on the inner peripheral side surface portion of the first regulating member 710 (see FIG. 4(c)), it is possible to lean on other chemicals 5 or lean against them. The existing one interferes with the overhang of the upper portion 712 and the inclined surface below the upper portion 712, so that the running of the medicines 5 on each other is eliminated. Since the riding up and the like have already been resolved to some extent by the first sorting member 610, they are almost resolved by further cancellation.

それから、薬剤5が規制機構700の第2規制部材720と仕分け機構600の中段垂下物622との間に来ると(図5(a)参照)、単独の薬剤5は、中段垂下物622と微かに干渉するが中段垂下物622との干渉が弱いので進行を妨げられることなく搬送される。これに対し、他の薬剤5に乗り上げているものや寄り掛かっている薬剤5は、中段垂下物622に対して単独の薬剤5のときより強く干渉するので、乗り上げ等が解消されることが多い。このときの干渉も、中段垂下物622が前段垂下物612よりも変形し易くて逃げやすいものなので、薬剤5が脆いものであっても壊れ難い。さらに、干渉した薬剤5は、薬剤搬送経路より内周側へ押されて傾斜回転体300の上へ戻されるか、第2仕分け部材620の方へ寄せられて薬剤搬送経路の上にとどまる。 Then, when the medicine 5 comes between the second restricting member 720 of the restricting mechanism 700 and the middle pendant 622 of the sorting mechanism 600 (see FIG. 5A), the single medicine 5 is slightly separated from the middle pendant 622. However, since the interference with the middle-stage hanging object 622 is weak, it is conveyed without hindering the progress. On the other hand, the drug 5 that is riding on or leaning against the other drug 5 interferes more strongly with the middle pendant 622 than when the drug 5 is a single drug, and therefore the riding and the like are often eliminated. .. The interference at this time is also easier for the middle pendant 622 to deform and escape than the front pendant 612, so that even if the medicine 5 is fragile, it is difficult to break. Further, the interfering drug 5 is pushed toward the inner peripheral side of the drug delivery route and returned to the inclined rotating body 300, or is moved toward the second sorting member 620 and stays on the drug delivery route.

さらに、薬剤5が規制機構700の第2規制部材720と仕分け機構600の後段垂下物632との間に来ると(図5(a)参照)、上下に重なっている薬剤5や横に並んでいる薬剤5は既にほとんど無くなっているが、薬剤搬送経路の上にとどまりつつも内周側に寄り過ぎている薬剤5はそれなりに有り得るところ、そのような薬剤5は、後段垂下物632と干渉して、薬剤搬送経路の上にとどまり続けながら第2仕分け部材620の方へ寄せられる。後段垂下物632との干渉は、小玉633が小粒なので、弱くて優しいが、引き付け部材640の引き付け力の加勢があるので、粘りもある。しかも、後段垂下物632が揺れたときでも、その揺れが引き付け部材640の引き付け力によって抑制されて直ぐに収まるので、薬剤5を第2仕分け部材620に寄せる付勢は安定して行われる。 Further, when the medicine 5 comes between the second restricting member 720 of the restricting mechanism 700 and the posterior pendant 632 of the sorting mechanism 600 (see FIG. 5(a)), the medicines 5 that are vertically overlapped and side by side Although the medicines 5 that have already existed have almost disappeared, it is possible that there are medicines 5 that remain on the medicine conveyance route but are too close to the inner peripheral side, and such medicines 5 interfere with the posterior pendant 632. Then, it is moved toward the second sorting member 620 while continuing to stay on the medicine transport path. Interference with the posterior hanging object 632 is weak and gentle because the small balls 633 are small particles, but it is also sticky because the attractive force of the attractive member 640 is applied. Moreover, even when the posterior pendant 632 sways, the sway is suppressed by the attracting force of the attracting member 640 and immediately settles, so that the drug 5 is urged toward the second sorting member 620 in a stable manner.

そして、薬剤5が規制機構700の第2規制部材720の後端部の横に来ると(図5(a)参照)、第1規制部材710の横に来たときについて上述したのと同様にして、下段部分721の横幅規制機能と上段部分722の高さ規制機能とによって最終的な薬剤整列処理が施され、薬剤5が上端周縁部230の薬剤搬送経路の上で一列に並ぶ。
このように、この薬剤フィーダ100では、前段垂下物612と第1規制部材710と中段垂下物622と後段垂下物632と第2規制部材720とが、薬剤の高さ規制と横幅規制との何れが主で何れが従かという相違はあるが、多くのものが両方の規制を行うので、環状回転体200の上端周縁部230の上の薬剤5は、粗密いずれの状態であっても、多段階で何度も繰り返される両規制によって、薬剤搬送経路の上で一列になる。
Then, when the medicine 5 comes to the side of the rear end portion of the second regulation member 720 of the regulation mechanism 700 (see FIG. 5A), the same manner as described above for the case of coming to the side of the first regulation member 710. Then, the final medicine alignment process is performed by the lateral width regulation function of the lower portion 721 and the height regulation function of the upper portion 722, and the medicines 5 are arranged in a line on the medicine conveyance path of the upper end peripheral portion 230.
As described above, in this medicine feeder 100, the front-stage hanging object 612, the first restricting member 710, the middle-stage hanging object 622, the rear-stage hanging object 632, and the second restricting member 720 are both the height restriction and the lateral width restriction of the medicine. However, many of them regulate both of them, so that the drug 5 on the upper end peripheral portion 230 of the annular rotating body 200 may have a large amount regardless of whether it is in a dense or dense state. Both regulations, which are repeated many times in stages, line the drug delivery path.

それから、薬剤5が排出ガイド13の外周側に来ると(図5(a)参照)、薬剤5は、環状回転体200の回転に伴って排出ガイド13の外周側面に沿って落下排出口14へ送り込まれる。その際、円板状などの多くの薬剤は、上端周縁部230との摩擦によって安定状態を保ちつつ上端周縁部230の上を移動するので、一つずつ落下排出口14へ入る。一方、球状などの転がり易い薬剤は、排出ガイド13に押されて環状回転体200の上端周縁部230の溝231の拡幅部から溝231の先端側を経て上端周縁部230の面取232へと移動するが(図2(b),図3参照)、溝231から面取232への移動タイミングが上端周縁部230の傾斜(β)によって安定化されるうえ(図2(c)参照)、その後の落下排出口14へ向けた移動が面取232の傾斜(α−β)によって迅速かつ安定したものにされるので、転がり易い薬剤も一つずつ落下排出口14へ入り込む。 Then, when the medicine 5 comes to the outer peripheral side of the discharge guide 13 (see FIG. 5A), the medicine 5 is dropped to the drop discharge port 14 along the outer peripheral side surface of the discharge guide 13 as the annular rotating body 200 rotates. Sent in. At this time, many drugs such as discs move on the upper end peripheral portion 230 while maintaining a stable state due to friction with the upper end peripheral portion 230, and thus enter the drop discharge port 14 one by one. On the other hand, a drug that easily rolls, such as a spherical shape, is pushed by the discharge guide 13 and moves from the widened portion of the groove 231 of the upper end peripheral portion 230 of the annular rotating body 200 to the chamfer 232 of the upper end peripheral portion 230 via the tip side of the groove 231. Although it moves (see FIGS. 2B and 3), the timing of movement from the groove 231 to the chamfer 232 is stabilized by the inclination (β) of the upper end peripheral portion 230 (see FIG. 2C). Since the subsequent movement toward the drop discharge port 14 is made quick and stable by the inclination (α-β) of the chamfer 232, the medicines that easily roll into the drop discharge port 14 one by one.

そして、落下排出口14に入った薬剤5は、落下経路をほぼ自由落下状態で落下して(図8(a)参照)、薬剤落下検出手段560の検出先を通過する。薬剤サイズの推定値がクリアされているとき即ちその薬剤5が最初の排出薬剤であるときには、そのときの通過時間を検出した検出時間長に応じて薬剤サイズが推定され、更に、その推定値に基づいて以後の回転駆動モータ540の回転速度ひいては回転容器200+300の回転速度が設定される。具体的には、薬剤サイズの推定値が大きいときには回転容器200+300を高速で回転させるが薬剤サイズの推定値が小さいときには回転容器200+300を低速で回転させるような速度設定が自動で行われて、以後は、その設定速度で回転容器200+300が回転する。そのため、小さめの薬剤については低速化によって不所望な多重落下が防止され、大きめの薬剤については高速化によって能率の向上が図られる。 Then, the medicine 5 that has entered the drop discharge port 14 drops in a substantially free fall state on the drop path (see FIG. 8A), and passes through the detection destination of the medicine drop detection means 560. When the estimated value of the medicine size is cleared, that is, when the medicine 5 is the first discharged medicine, the medicine size is estimated according to the detection time length of the passage time detected at that time, and the estimated value is further calculated. Based on this, the subsequent rotation speed of the rotary drive motor 540 and, by extension, the rotation speed of the rotary container 200+300 are set. Specifically, when the estimated value of the medicine size is large, the rotary container 200+300 is rotated at a high speed, but when the estimated value of the medicine size is small, the rotational container 200+300 is automatically rotated at a low speed. Causes the rotating container 200+300 to rotate at the set speed. Therefore, an undesired multiple drop can be prevented by decreasing the speed of a small medicine, and the efficiency can be improved by increasing the speed of a large medicine.

さらに、薬剤落下検出手段560にて薬剤の落下が検出されると、その度に、コントローラ570において薬剤排出動作制御プログラムから剤数管理プログラムへ薬剤一個排出済みの通知がなされる。そして、薬剤排出の回数が薬剤排出指示の指示値に到達したことが剤数管理プログラムによって確認されると、剤数管理プログラムから薬剤排出動作制御プログラムへ排出動作停止の指示が出されて、薬剤排出動作制御プログラムの制御によって回転駆動モータ540の動作が停止されるので、薬剤排出動作が止まる。
こうして、薬剤排出指示で指示された個数の薬剤5が薬剤フィーダ100から送り出され、一の薬剤排出指示に応じた薬剤供給が迅速かつ的確に完了する。
Further, each time the medicine drop detecting means 560 detects the drop of the medicine, the controller 570 notifies the medicine discharge operation control program to the medicine number management program that one medicine has been discharged. Then, when it is confirmed by the drug number management program that the number of drug ejections reaches the command value of the drug ejection instruction, the drug number management program issues an instruction to stop the ejection operation to the drug ejection operation control program, Since the operation of the rotary drive motor 540 is stopped by the control of the discharge operation control program, the medicine discharge operation is stopped.
In this way, the number of medicines 5 instructed by the medicine discharge instruction is sent out from the medicine feeder 100, and the medicine supply according to one medicine discharge instruction is completed promptly and accurately.

上述の動作説明では煩雑化の回避のために割愛したが、薬剤フィーダ100に容器延伸体800が装着されていて(図7(a)の左奥の物を参照)、そこに環状回転体200を超える高さまで薬剤5が投入されていた場合の動作について説明を追加する。
この場合、傾斜回転体300から環状回転体200へ薬剤5が乗り移る箇所の直ぐ後方位置から、排出ガイド13の手前までは(図5(a)参照)、環状回転体200の上端周縁部230の上の薬剤搬送経路と傾斜回転体300の上方空間とが容器延伸体800の垂下部830によって仕切られているので(図6(a)参照)、容器延伸体800の筒部820の中の薬剤5が不所望に雪崩れ込むことはなく、薬剤5は、貫通穴811の膨らみ812を通って(図6(b)参照)、少しずつ薬剤搬送経路の上に乗り込む。
Although omitted in order to avoid complication in the above description of the operation, the container feeder 800 is attached to the drug feeder 100 (see the one on the left rear side of FIG. 7A), and the annular rotating body 200 is provided there. A description will be added to the operation when the medicine 5 is loaded to a height exceeding the above.
In this case, from the position immediately behind the position where the medicine 5 is transferred from the inclined rotary body 300 to the annular rotary body 200 and before the discharge guide 13 (see FIG. 5A), the upper end peripheral portion 230 of the annular rotary body 200 is located. Since the upper drug delivery path and the space above the inclined rotating body 300 are partitioned by the hanging part 830 of the container extending body 800 (see FIG. 6A), the drug in the tubular portion 820 of the container extending body 800 is partitioned. The drug 5 does not undesirably avalanche, and the drug 5 gradually passes through the bulge 812 of the through hole 811 (see FIG. 6B) and gradually gets on the drug transport path.

同じく容器延伸体800が薬剤フィーダ100に装着されている場合、仕分け機構600や規制機構700によって環状回転体200の上端周縁部230の上の薬剤搬送経路から傾斜回転体300の上へ戻された薬剤5は(図5(a)参照)、環状回転体200の内周壁面(図2(a)参照)と容器延伸体800の垂下部830の外周面(図6参照)との隙間に収まってから、傾斜回転体300によって容器延伸体800の貫通穴811の下方へ戻される。傾斜回転体300の上面のうち上面周縁部330には引渡部340や押上部350更には凸部360まで形成されているので、それで運ばれる薬剤5は、容器延伸体800の中の多数の薬剤5の下方に潜るような状況であっても的確に送り込まれる。 Similarly, when the container extending body 800 is attached to the medicine feeder 100, it is returned from the medicine conveying path on the upper end peripheral portion 230 of the annular rotating body 200 onto the inclined rotating body 300 by the sorting mechanism 600 and the regulating mechanism 700. The medicine 5 (see FIG. 5A) is contained in the gap between the inner peripheral wall surface of the annular rotating body 200 (see FIG. 2A) and the outer peripheral surface of the hanging portion 830 of the container extending body 800 (see FIG. 6). Then, it is returned to below the through hole 811 of the container extending body 800 by the inclined rotating body 300. Since the transfer portion 340, the push-up portion 350, and the convex portion 360 are formed on the upper surface peripheral portion 330 of the upper surface of the inclined rotating body 300, the medicine 5 carried by the transfer portion 340 is a large number of medicines in the container extending body 800. Even if it dives below 5, it will be sent properly.

また、コントローラ570の制御方式についても、説明を追加すると、回転容器200+300が既述した正逆同時駆動の排出動作モードだけでなく、それとは少し異なる上述の謂わば片方逐次逆転式の排出動作モードも選択できるようにもなっていて、後者の逐次逆転式の排出動作モードが選択されている場合は、薬剤5の排出が一個でも検出されるとその度に傾斜回転体300だけを少し逆回転させることが行われる。これによって、環状回転体200の上端周縁部230の上の薬剤搬送経路の搬送速度を落とすこと無く、転がりやすい薬剤5についても過剰排出が的確に防止されるが、それに加え、正転だけでは得られない撹拌効果をも逆転によって発揮することができる。特に、傾斜回転体300の押上部350に付設の凸部360は逆転時にも大きな撹拌効果を発揮する。なお、正転に対する逆転の割合は、上述のような毎回に限られる訳でなく、二回の正転ごとに一回の逆転や、数回の正転ごとに一回の逆転など、適宜選択できるようになっていても良い。 Further, regarding the control method of the controller 570, if the description is added, not only the discharge operation mode of the forward/backward simultaneous drive of the rotating container 200+300 described above but also a slightly different so-called one-sided sequential reversal discharge operation mode described above. When the discharge operation mode of the sequential reversal type is selected, only the inclined rotating body 300 is slightly rotated in the reverse direction every time even one discharge of the medicine 5 is detected. Is done. As a result, the excessive discharge of the drug 5 that easily rolls is accurately prevented without slowing down the transport speed of the drug transport path on the upper end peripheral portion 230 of the annular rotator 200. A stirring effect that cannot be achieved can be exhibited by reversing. In particular, the convex portion 360 attached to the push-up portion 350 of the inclined rotary body 300 exerts a great stirring effect even when it is rotated in reverse. It should be noted that the ratio of reverse rotation to forward rotation is not limited to each time as described above, and it can be selected as appropriate, such as once every two forward rotations or once every several forward rotations. You may be able to do it.

さらに、薬剤フィーダ100にて取り扱う薬剤が変更になったときなどに、薬剤フィーダ100の中に薬剤が未だ残っている場合は、その残薬を回収することになるが、この薬剤フィーダ100には二つの残薬回収手段が具備されている。
一つ目は、回転容器200+300を十分な時間に亘って継続的に逆転させるものであり、この場合、環状回転体200の上に乗っていた薬剤が逆転時に仕分け機構600や規制機構700更には排出ガイド13の内周側延長面などによって環状回転体200の内側に押し込まれて傾斜回転体300の上に集まるので、それを手作業等で取り出す。
二つ目は、回転容器200+300を排出完了まで継続的に正転させるものであり、この場合、フィーダ単独使用の場合は排出薬剤を回収用容器などで回収し、分包機組込使用の場合は分包紙に封入して回収する。
Furthermore, when the medicine handled by the medicine feeder 100 is changed, if the medicine remains in the medicine feeder 100, the remaining medicine is collected. Two residual drug recovery means are provided.
One is to continuously rotate the rotating container 200+300 in reverse for a sufficient time. In this case, when the medicine on the annular rotating body 200 is reversed, the sorting mechanism 600, the regulation mechanism 700, and The discharge guide 13 is pushed into the inside of the annular rotating body 200 by the extension surface on the inner peripheral side and gathers on the inclined rotating body 300, so that it is taken out by hand or the like.
The second is to continuously rotate the rotating container 200+300 forward until the discharge is completed. In this case, in the case of using the feeder alone, the discharged drug is collected in a collecting container, and in the case of using the packing machine, Enclose in packaging paper and collect.

また、薬剤フィーダ100にて取り扱う薬剤が変更になったような場合は、型用薬剤5aも取り替えることになるので、先ずはセット済みの型用薬剤5aを取り外さなければならないが、規制機構700の型置場740の小蓋741が透明なことから、そこに置かれていた型用薬剤5aの有無や形状等が目視で容易かつ確実に分かるので、不所望な取り忘れは発生し難い。仕分け機構600の手動調整機構650に置かれていた型用薬剤5aについても、挟持方式で密閉されておらず、目視可能なので、同様である。 Further, when the medicine handled by the medicine feeder 100 is changed, the molding medicine 5a is also replaced. Therefore, the set molding medicine 5a must be removed first. Since the small lid 741 of the mold storage space 740 is transparent, the presence or absence of the mold medicine 5a placed there, the shape, and the like can be easily and surely visually confirmed, so that undesired forgetting is unlikely to occur. The same applies to the mold medicine 5a placed on the manual adjustment mechanism 650 of the sorting mechanism 600 because it is not sealed by the sandwiching method and is visible.

[その他]
上記実施例では、第2仕分け部材620の手動調整機構650や規制機構700の型置場740に、薬剤5から選出した型用薬剤5aを置いていたが、型用薬剤5aは、薬剤5から選出したものに限られる訳でなく、要部寸法が同じであれば薬剤以外の代用品であっても良い。
[Other]
In the above-described embodiment, the mold medicine 5a selected from the medicine 5 is placed in the mold adjustment mechanism 650 of the second sorting member 620 and the mold storage 740 of the regulation mechanism 700, but the mold medicine 5a is selected from the medicine 5. It is not limited to the above-mentioned ones, and substitutes other than medicines may be used as long as the dimensions of the main part are the same.

上記実施例では、仕分け機構600のうち、第2仕分け部材620の支持部材621だけが跨ぎ仕分け部材になっており、第1仕分け部材610の支持部材611は跨ぎ仕分け部材になっていなかったが、これは必須でなく、第1仕分け部材610の支持部材611まで跨ぎ仕分け部材になっていても良い。 In the above-described embodiment, in the sorting mechanism 600, only the support member 621 of the second sorting member 620 is the straddle sorting member, and the support member 611 of the first sorting member 610 is not the straddle sorting member. This is not essential, and the support member 611 of the first sorting member 610 may also be a straddling sorting member.

上記実施例では、薬剤の過剰な転動の防止のために傾斜回転体300を少しだけ逆転させる制御や使い方があることについても説明したが、正転に対する逆転の割合をもっと増やしても良い。上述した傾斜回転体300には凸部360が形成されていることから、傾斜回転体300は逆転時にも薬剤5を押し上げて環状回転体200に受け渡すことができるので、正転と逆転とを適宜な割合で交互に繰り返すことにより、回転容器200+300の中の薬剤5をしっかり撹拌しながら受け渡すといったこともできる。 In the above-mentioned embodiment, it was explained that there is a control and a method of slightly reversing the inclined rotating body 300 in order to prevent excessive rolling of the medicine, but the ratio of the reverse rotation to the normal rotation may be further increased. Since the convex portion 360 is formed on the tilted rotary body 300 described above, the tilted rotary body 300 can push up the medicine 5 and deliver it to the annular rotary body 200 even during reverse rotation, so that normal rotation and reverse rotation can be performed. By alternately repeating at an appropriate ratio, it is possible to deliver the drug 5 in the rotary container 200+300 while firmly stirring it.

上記実施例では、傾斜回転体装着検出手段550として、傾斜回転体300の回転軸部370の軸支部に組み込まれたフォトセンサを例示したが、傾斜回転体装着検出手段550は、適切な姿勢で装着された傾斜回転体300を検出できれば他のセンサでも良く、例えばメカニカルスイッチでも良い。傾斜回転体装着検出手段550の装着箇所も、回転軸部370の軸支部の中に限られる訳でなく、例えば回転駆動モータ541,542の支持板などであっても良く、回転駆動モータ541,542の中間位置などであっても良い。検出手法も、回転軸部370を直に検出するものに限られる訳でなく、適宜なリンク部材などを介して間接的に検出するようにしても良い。 In the above-described embodiment, as the tilted rotary body attachment detection means 550, the photosensor incorporated in the shaft support portion of the rotary shaft portion 370 of the tilted rotary body 300 is illustrated, but the tilted rotary body attachment detection means 550 is in an appropriate posture. Another sensor may be used as long as it can detect the mounted tilting rotor 300, and for example, a mechanical switch may be used. The mounting position of the inclined rotary member mounting detection means 550 is not limited to the shaft support portion of the rotary shaft portion 370, and may be, for example, a support plate of the rotary drive motors 541 and 542. It may be an intermediate position of 542 or the like. The detection method is not limited to the method of directly detecting the rotary shaft portion 370, and may be indirectly detected via an appropriate link member or the like.

上記実施例に係る図8(a)では、回転駆動モータ541,532を回転駆動部材511,512に比べて小さめに表示したが、回転駆動モータ541,532がもっと大きくても良く、回転駆動部材511,512がもっと小さくても良い。また、回転駆動モータ541と回転駆動部材511が傾いていないのに対し、回転駆動モータ542と回転駆動部材512は傾いていたが、何れの設置についても傾斜させるか否かは任意である。さらに、回転駆動モータ541と回転駆動部材511の左右位置や、回転駆動モータ542と回転駆動部材512の左右位置も、任意の設計事項である。 In FIG. 8A according to the above embodiment, the rotary drive motors 541 and 532 are shown smaller than the rotary drive members 511 and 512, but the rotary drive motors 541 and 532 may be larger than the rotary drive members 511 and 512. 511 and 512 may be smaller. Further, although the rotary drive motor 541 and the rotary drive member 511 are not inclined, the rotary drive motor 542 and the rotary drive member 512 are inclined, but it is arbitrary whether or not they are inclined in any installation. Further, the left and right positions of the rotary drive motor 541 and the rotary drive member 511 and the left and right positions of the rotary drive motor 542 and the rotary drive member 512 are also optional design matters.

本発明の薬剤フィーダは、錠剤分包機に搭載された多数の整列盤回転タイプ薬剤フィーダのうち一部のもの或いは全部を代替するのに用いても良く、薬剤フィーダを一個か少数個しか搭載しない錠剤分割器に搭載しても良く、さらには薬瓶へ錠剤等の薬剤を充填する装置などにおいて逐次送出した薬剤の個数を数え上げる錠剤カウンタ(薬剤カウンタ)などに搭載しても良い。 The drug feeder of the present invention may be used to replace a part or all of a large number of aligning plate rotary type drug feeders mounted on a tablet packaging machine, and only one or a few drug feeders are mounted. It may be mounted on a tablet divider, or may be mounted on a tablet counter (medicine counter) for counting the number of medicines sequentially delivered in a device for filling medicines such as tablets into a medicine bottle.

5…薬剤、5a…型用薬剤、5b…ランダム収容薬剤、5c…整列済み薬剤、
10…薬剤フィーダ、
11…周壁、12…搬送面ガイド、13…排出ガイド、14…落下排出口、
20…環状回転体、21…下部、22…上部、23…上端周縁部(薬剤搬送経路)、
30…傾斜回転体、31…中央突起、32…央部、33…周縁部、
20+30…回転容器、
40…支承機構、41…受動部材、
42…大径部外装回転伝動部材、43…小径部外装回転伝動部材、
50…回転駆動機構、51…回転駆動部材、
52…大径部、53…小径部、54…回転駆動モータ、
60…仕分け部材、61…基端部、62…先端部(薬剤当接部位)、63…支持部、
70…規制機構、71…第1規制部材、72…第2規制部材、
73…リンク機構、74…型置場、
100…薬剤フィーダ、
110…大蓋、
200+300…回転容器、
200…環状回転体、
201…縦線、210…下部、220…上部、
230…上端周縁部(薬剤搬送経路)、
231…溝、232…面取、233…彫り込み、
300…傾斜回転体、
310…丸板部、320…上面央部、321…並行波状凹凸、
330…上面周縁部、340…引渡部、350…押上部、351…央部延長面、
360…凸部、361…基部、362…延伸部、370…回転軸部
500…回転駆動機構、
511,512…回転駆動部材、541,542…回転駆動モータ、
550…傾斜回転体装着検出手段、560…薬剤落下検出手段、
570…コントローラ、
600…仕分け機構
610…第1仕分け部材、611…支持部材、612…前段垂下物、613…大玉、
620…第2仕分け部材(跨ぎ仕分け部材)、
621…支持部材(跨ぎ部)、622…中段垂下物(横並び垂下物)、623…中玉、
632…後段垂下物(横並び垂下物)、633…小玉、640…引き付け部材、
650…手動調整機構、651…下限設定機構、652…目盛部材、
700…規制機構、
710…第1規制部材、711…下段部分、712…上段部分、
720…第2規制部材、721…下段部分、722…上段部分、
730…バネ(付勢部材)、740…型置場、
741…小蓋(透明部材)、742…止めネジ(固定部材)、
800…容器延伸体、
810…板部、811…貫通穴、820…筒部、830…垂下部
5... Drug, 5a... Mold drug, 5b... Randomly housed drug, 5c... Aligned drug,
10... Drug feeder,
11... Peripheral wall, 12... Conveying surface guide, 13... Discharge guide, 14... Drop discharge port,
20... Annular rotator, 21... Lower part, 22... Upper part, 23... Upper end peripheral part (medicine conveying path),
30... Inclined rotating body, 31... Central protrusion, 32... Central part, 33... Peripheral part,
20+30...Rotating container,
40... Bearing mechanism, 41... Passive member,
42... Large diameter part exterior rotation transmission member, 43... Small diameter part exterior rotation transmission member,
50... Rotational drive mechanism, 51... Rotational drive member,
52... Large diameter part, 53... Small diameter part, 54... Rotation drive motor,
60... Sorting member, 61... Base end part, 62... Tip part (medicine contact part), 63... Support part,
70... Regulation mechanism, 71... 1st regulation member, 72... 2nd regulation member,
73... Link mechanism, 74... Mold storage,
100... Drug feeder,
110... large lid,
200+300...Rotating container,
200... annular rotating body,
201...vertical line, 210...bottom, 220...top,
230... Upper peripheral portion (medicine transfer route),
231... Groove, 232... Chamfer, 233... Engraving,
300... Tilt rotor,
310... Round plate part, 320... Central part of upper surface, 321... Parallel wavy unevenness,
330... peripheral part of upper surface, 340... transfer part, 350... push up part, 351... extension part of central part,
360... Convex part, 361... Base part, 362... Stretching part, 370... Rotating shaft part 500... Rotation drive mechanism,
511, 512... Rotational drive member, 541, 542... Rotational drive motor,
550... Inclined rotor mounting detection means, 560... Drug drop detection means,
570... controller,
600... Sorting mechanism 610... First sorting member, 611... Supporting member, 612... Preliminary hanging object, 613... Large ball,
620... Second sorting member (stripping sorting member),
621... Support member (straddling part), 622... Middle-stage hanging object (side-by-side hanging object), 623... Middle-sized ball,
632...Post-stage hanging objects (side-by-side hanging objects), 633...small balls, 640...attracting members,
650... Manual adjustment mechanism, 651... Lower limit setting mechanism, 652... Scale member,
700...Regulatory mechanism,
710... First regulating member, 711... Lower part, 712... Upper part,
720... 2nd control member, 721... lower part, 722... upper part,
730... Spring (biasing member), 740... Mold storage,
741... Small lid (transparent member), 742... Set screw (fixing member),
800... stretched container,
810... Plate part, 811... Through hole, 820... Cylindrical part, 830... Hanging part

Claims (4)

縦線を中心として軸回転可能な外側の環状回転体と、前記縦線から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる規制部材と、前記規制部材の後方に設けられていて前記環状回転体の前記上端周縁部の上の薬剤を内周側から外周側へ導いて落下排出口へ送り込む排出ガイドとを備えた薬剤フィーダであって、
前記環状回転体は、その前記上端周縁部に、径方向に延びており且つ径方向の途中で拡幅していて該拡幅部位より外周側でも内周側でも幅が狭くなっており更に内周側では前記上端周縁部の辺縁に達している溝が周方向に列設されている、ことを特徴とする薬剤フィーダ。
An outer ring-shaped rotary body that is axially rotatable about a vertical line, and a hollow body of the ring-shaped rotary body that is mounted inside the ring-shaped rotary body in a state that is axially rotatable about an inclined line inclined from the vertical line. An inclined rotator to be closed, a regulating member for aligning the solid medicine carried by the rotation of the inclined rotator onto the upper end peripheral portion of the annular rotator during the rotation of the annular rotator, and the regulating member A drug feeder provided with a discharge guide that is provided at the rear of and guides the drug on the upper end peripheral portion of the annular rotary member from the inner peripheral side to the outer peripheral side and sends it to the drop discharge port .
The annular rotating body extends in the radial direction at the upper end peripheral portion thereof, widens in the middle of the radial direction, and is narrower on the outer peripheral side or the inner peripheral side than the widened portion, and further on the inner peripheral side. Then, the groove|channel which reaches |attains the edge of the said upper end peripheral part is provided in a row in the circumferential direction, The medicine feeder characterized by the above-mentioned.
前記環状回転体は、その前記上端周縁部において隣り合っている前記溝の間に、内周寄りほど深い湾状の彫り込みが形成されており、前記彫り込みも内周側では前記上端周縁部の辺縁に達している、ことを特徴とする請求項1記載の薬剤フィーダ。 The annular rotating body has a bay-shaped engraving deeper toward the inner circumference between the grooves adjacent to each other at the upper end peripheral edge, and the engraving also has a side of the upper end peripheral edge on the inner peripheral side. The drug feeder according to claim 1, wherein the drug feeder reaches an edge . 縦線を中心として軸回転可能な外側の環状回転体と、前記縦線から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる規制部材とを備えた薬剤フィーダであって、
前記環状回転体は、その前記上端周縁部に、径方向に延びており且つ径方向の途中で拡幅している溝が周方向に列設されており、前記環状回転体の前記上端周縁部の外周部分が一周に亘って面取りされており、その面取にまで前記溝が達しており、
前記環状回転体の前記上端周縁部の上の薬剤を内周側から外周側へ導いて落下排出口へ送り込む排出ガイドが設けられており、前記縦線が鉛直線から傾斜しており、その傾斜方向が前記環状回転体のうち前記落下排出口寄りの部位を高める向きになっており、前記傾斜の程度が前記面取の傾きより小さいことを特徴とする薬剤フィーダ。
An outer ring-shaped rotary body that is axially rotatable about a vertical line, and a hollow body of the ring-shaped rotary body that is mounted inside the ring-shaped rotary body in a state that is axially rotatable about an inclined line inclined from the vertical line. A medicine provided with an inclined rotating body for closing and a regulating member for aligning the solid medicine carried from above by the rotation of the inclined rotating body onto the upper end peripheral portion of the annular rotating body when the annular rotating body is rotated. A feeder,
It said annular rotating body is in its said upper peripheral edge, a groove which is widened in the middle of and radially extend radially circumferential direction are arrayed in, of the upper peripheral portion of the annular rotary body The outer peripheral portion is chamfered over the entire circumference, and the groove reaches the chamfer ,
A discharge guide is provided for guiding the medicine on the upper end peripheral portion of the annular rotating body from the inner peripheral side to the outer peripheral side and sending it to the drop discharge port, and the vertical line is inclined from the vertical line, and its inclination the has become the direction of increasing the portion of the drop outlet closer, you wherein a degree of the inclination is smaller than the slope of the chamfer pharmacist feeder of direction the annular rotary body.
前記傾斜回転体および前記環状回転体を回転させる回転駆動機構が前記傾斜回転体の回転方向と前記環状回転体の回転方向とを個別に反転しうるものであり、前記環状回転体を正転させつつ前記落下薬剤検出手段の薬剤落下検出に応じて前記環状回転体を一時的に逆転させる制御手段が設けられている、ことを特徴とする請求項1乃至3の何れか一項に記載の薬剤フィーダ。 Wherein Ri tilt rotation unit and Der those rotary drive mechanism for rotating the annular rotary body is capable of reversing the rotational direction of the annular rotor and the rotation direction of the inclined rotary member individually forward the annular rotary body depending on the drug drop detection of the drop drug detecting means while according to any one of claims 1 to 3 wherein the control means for temporarily reversing the annular rotary body is provided, it is characterized by Drug feeder.
JP2020012127A 2020-01-29 2020-01-29 Drug feeder Active JP6736075B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2020012127A JP6736075B1 (en) 2020-01-29 2020-01-29 Drug feeder
EP21747412.1A EP4098594A4 (en) 2020-01-29 2021-01-28 Drug feeder
PCT/JP2021/003052 WO2021153674A1 (en) 2020-01-29 2021-01-28 Drug feeder
CN202180011421.2A CN115038422A (en) 2020-01-29 2021-01-28 Medicine feeder
CA3169692A CA3169692A1 (en) 2020-01-29 2021-01-28 Medicine feeder
US17/795,695 US11759396B2 (en) 2020-01-29 2021-01-28 Medicine feeder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020012127A JP6736075B1 (en) 2020-01-29 2020-01-29 Drug feeder

Publications (2)

Publication Number Publication Date
JP6736075B1 true JP6736075B1 (en) 2020-08-05
JP2021115362A JP2021115362A (en) 2021-08-10

Family

ID=71892412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020012127A Active JP6736075B1 (en) 2020-01-29 2020-01-29 Drug feeder

Country Status (1)

Country Link
JP (1) JP6736075B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022102638A1 (en) * 2020-11-12 2022-05-19 株式会社湯山製作所 Tablet dispensing device and portioning and packaging machine
WO2022124369A1 (en) * 2020-12-11 2022-06-16 株式会社トーショー Drug feeder
WO2022186348A1 (en) * 2021-03-05 2022-09-09 株式会社トーショー Drug feeder
WO2022220167A1 (en) 2021-04-15 2022-10-20 株式会社トーショー Medicine packaging machine
WO2022250024A1 (en) 2021-05-25 2022-12-01 株式会社トーショー Medicine packaging machine
JP7424634B2 (en) 2020-12-11 2024-01-30 株式会社トーショー drug feeder

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022102638A1 (en) * 2020-11-12 2022-05-19 株式会社湯山製作所 Tablet dispensing device and portioning and packaging machine
WO2022124369A1 (en) * 2020-12-11 2022-06-16 株式会社トーショー Drug feeder
JP7424634B2 (en) 2020-12-11 2024-01-30 株式会社トーショー drug feeder
WO2022186348A1 (en) * 2021-03-05 2022-09-09 株式会社トーショー Drug feeder
WO2022220167A1 (en) 2021-04-15 2022-10-20 株式会社トーショー Medicine packaging machine
WO2022250024A1 (en) 2021-05-25 2022-12-01 株式会社トーショー Medicine packaging machine

Also Published As

Publication number Publication date
JP2021115362A (en) 2021-08-10

Similar Documents

Publication Publication Date Title
JP6736075B1 (en) Drug feeder
JP6736064B2 (en) Drug feeder
US10486889B2 (en) Drug feeder
EP1380502B1 (en) Tablet packing apparatus
US7861845B1 (en) Roller sorter system
JP6736074B1 (en) Drug feeder
JP2014055775A (en) Automatic weighing conveyor device
JP7337382B2 (en) drug feeder
JP5383640B2 (en) Chemical dispensing device
JP7337383B2 (en) drug feeder
JP7281145B2 (en) drug feeder
JP7325756B2 (en) drug feeder
WO2021153674A1 (en) Drug feeder
JP7337388B2 (en) drug feeder
JP7424634B2 (en) drug feeder
WO2023181610A1 (en) Drug feeder and tablet packing machine
JP2022100541A (en) Medicine feeder
WO2022186348A1 (en) Drug feeder
JP2022106557A (en) Medicine feeder and dispensing system
JP3109112U (en) Improved structure of vending machines
US10329098B2 (en) Automated vial hopper and feeder assembly

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200129

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20200203

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20200217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200421

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200507

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200707

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200707

R150 Certificate of patent or registration of utility model

Ref document number: 6736075

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250